Page 11234..1020..»

You are currently browsing the Nano Medicine category

Nanomedicine – 1st Edition – Elsevier

§ October 2nd, 2018 § Filed under Nano Medicine Comments Off on Nanomedicine – 1st Edition – Elsevier

Contributor contact details

Woodhead Publishing Series in Biomaterials

Dedication

Part I: Materials, properties and considerations

Chapter 1: Introduction to nanomedicine

Abstract:

1.1 Introduction: basic concepts of nanomedicine

1.2 Public perception of nanomedicine

1.3 Scientific principles and applications of nanomedicine

1.4 Future trends in nanomedicine

Chapter 2: Trends in nanomedicine

Abstract:

2.1 Introduction

2.2 The rise of nanomedicine

2.3 Diagnostics and medical records

2.4 Treatment

2.5 Future trends

Chapter 3: Biomedical nanocrystalline metals and alloys: structure, properties and applications

Abstract:

3.1 Introduction

3.2 Synthesis and structure of nanocrystalline metals and alloys

3.3 Properties of nanocrystalline metals and alloys

3.4 Biocompatibility of nanocrystalline metals and alloys

3.5 Applications of nanocrystalline metals and alloys

3.6 Future trends

3.7 Sources of further information and advice

Chapter 4: Nanoporous gold for biomedical applications: structure, properties and applications

Abstract:

4.1 Introduction

4.2 Medical applications

4.3 Biosensor applications

4.4 Alloy formation

4.5 Dealloying of goldsilver alloy

4.6 Mechanical properties of nanoporous gold

4.7 Electronic properties of nanoporous gold

4.8 Conclusions

Chapter 5: Hydroxyapatite (HA) coatings for biomaterials

Abstract:

5.1 Introduction

5.2 Hydroxyapatite (HA) coatings

5.3 HA coatings by plasma spraying

5.4 Properties of plasma-sprayed coatings

5.5 Biomimetic HA coatings

5.6 HA coatings by sol-gel deposition

5.7 Miscellaneous deposition techniques for HA coatings

5.8 Conclusions

5.9 Future trends

5.10 Acknowledgement

Part II: Nanomedicine for therapeutics and imaging

Chapter 6: Calcium phosphate-coated magnetic nanoparticles for treating bone diseases

Abstract:

6.1 Introduction

6.2 Iron oxide magnetic nanoparticle synthesis

6.3 Surface modification of iron oxide magnetic nanoparticles

6.4 Characterization of iron oxide magnetic nanoparticles

6.5 Biological applications of magnetic nanoparticles

6.6 Conclusions

6.7 Future trends

Chapter 7: Orthopedic carbon nanotube biosensors for controlled drug delivery

Abstract:

7.1 Introduction

7.2 Carbon nanotubes for electrochemical biosensing

7.3 Carbon nanotube-based in situ orthopedic implant sensors

7.4 Electrically controlled drug-delivery systems for infection and inflammation

7.5 Critical issues in developing in situ orthopedic implantable sensors and devices

7.6 Conclusions

Chapter 8: Nanostructured selenium anti-cancer coatings for orthopedic applications

Abstract:

8.1 Introduction

8.2 Selenium as an anti-cancer implant material

8.3 Nanostructured selenium coatings: a novel approach of using selenium to create anti-cancer biomaterials

8.4 In vitro biological assays for uncoated and selenium-coated metallic substrates

8.5 The effectiveness of titanium and stainless steel substrates

8.6 Coarse-grained Monte Carlo computer simulation of fibronectin adsorption on nanometer rough surfaces

8.7 Conclusions

Chapter 9: Nanoparticulate targeted drug delivery using peptides and proteins

Abstract:

9.1 Introduction

9.2 Peptides and proteins for targeted drug delivery

9.3 Drug-peptide conjugates

9.4 Peptide-functionalized drug delivery systems

9.5 Peptide-targeted drug delivery across the intestine

9.6 Peptide-targeted drug delivery across the blood-brain barrier (BBB)

9.7 Peptide-targeted drug delivery for cancer applications

9.8 Peptide-targeted drug delivery for the liver

9.9 Conclusions and future trends

Chapter 10: Nanotechnology for DNA and RNA delivery

Abstract:

10.1 Introduction to DNA and RNA delivery

10.2 Advanced DNA/RNA delivery approaches in nanotechnology

10.3 Nanomaterial applications for DNA/RNA delivery

10.4 Novel vaccines

10.5 Molecular probes and images

10.6 Conclusions and future trends

Chapter 11: Gold nanoshells for imaging and photothermal ablation of cancer

Abstract:

11.1 Introduction

11.2 The impact of cancer

11.3 Cancer biology

11.4 Nanotechnology and cancer treatment

Go here to read the rest:
Nanomedicine – 1st Edition – Elsevier

Read the Rest...

Nanomedicine Conferences | Nanotechnology Events …

§ September 20th, 2018 § Filed under Nano Medicine Comments Off on Nanomedicine Conferences | Nanotechnology Events …

About Conference

ME Conferences invites all the participants from all over the world to attendNanomedicine and Nanotechnology in Health CareDuring 17-19 September, 2018 at Abu Dhabi, UAE. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. And it provides an opportunity to learn about the complexity of the Diseases, discuss interventional procedures, look at new and advances in Nanotechnology and their efficiency and efficacy in diagnosing and treating various diseases and also in Healthcare treatments.

ME Conferences organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 1,00,000 eminent personalities, reputed scientists as editorial board and organizing committee members. ME Conferences journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing.ME Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, international workshops, world class international exhibitions and poster presentations.

Why to attend?

This Conference Nanomedicinemeet 2018 will focus on Healthcare and Medicine. World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields Nanotechnology and Engineering, Medical Nanotechnology, Tissue Engineering are hallmarks of this conference. Nanomedicinemeet-2018 is an exciting opportunity to showcase the modern technology, the new products of your company, and/or the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent researches on Nanotechnology, MaterialScienceand other interesting topics.

Target Audience:

The termNano medicineencompasses a broad range of technologies and materials. Types of nanomaterials that have been investigated for use as drugs,, drug carriersor other Nonmedical agents. There has been steep growth in development of devices that integrate nanomaterials or other nanotechnology. Thenanotechnology-based medical devices market is categorized into three major segments, namely, therapeutic applications, diagnostics applications, and research applications. Rising incidence of lifestyle and age-related disorders (such as cardiovascular and hearing disorders) has contributed significantly to the growth of the nanotechnology-based active implantable devices market. Nanotechnology, or systems/device manufacture at the molecular level, is a multidisciplinary scientific field undergoing explosive development. The genesis of nanotechnology can be traced to the promise of revolutionary advances across medicine, communications and genomics. On the surface, miniaturization provides cost effective and more rapidlyfunctioningbiological components. Less obvious though is the fact that Nanometer sized objects also possess remarkableself-ordering and assemblybehaviors under the control of forces quite different from macro objects.

Advances in technology have increased our ability to manipulate the world around us . Nanotechnology is rapidly emerging within the realm of medicine. Nanomedicine is the process of diagnosing, treating, and preventing disease andtraumatic injury, of relieving pain, and of preserving and improving human health, using molecular tools and molecular knowledge of the human body. An exciting and promising area of Nano technological development is the building of Nanorobots. Highly precise positioning techniques are required in Miniaturing in chip technology, optics , micro mechanic, medicine , gene and biotechnology. The new manipulation technology is the desire to enter the micro and Nano world not only by viewing but also acting, alteringmicro andNanosized objects. Nanorobots plays a critical roles for many applications in the human body, such astargetingtumoral lesionsfor therapeutic purposes, miniaturization of the power source with an effective onboard controllable propulsion and steering system have prevented the implementation of such mobile robots.

The therapeutic properties of light have been known for thousands of years, but it was only in the last century that photodynamic therapy (PDT) was developed. It is an emerging modality for the treatment of a variety of diseases that require the killing of pathological cells (e.g. cancer cells or infectious micro-organisms) or the removal of unwanted tissue (e.g. neovascularization in the choroid or atherosclerotic plaques in the arteries). It is based on the excitation of nontoxic photosensitizers.Photodynamic therapy(PDT) uses the combination of dyes with visible light to produce reactive oxygen species and kill bacteria and destroy unwanted tissue. Nanotechnology plays a great role insolubilizing thephotosensitizers, metal nanoparticles can carry out Plasmon resonance enhancement, andfullerenescan act as photosensitizers, themselves.

Nanotechnology is becoming increasingly important for the several sectors. Promising results and applications are already being developed in the areas of nutrient delivery systems through bioactive Nano encapsulation,biosensorsto detect and quantifypathogens organic compounds. The sensitivity and performance of biosensors is being improved by using nanomaterials for their construction. The use of these nanomaterials has allowed the introduction of many new signal transduction technologies in biosensors. Many scientists have involved themselves to know the application and the benefits of nanotechnology in different areas of food industry that include bioactive Nano encapsulation, edible thin film, packages andNano sensors.

Green chemistry and Nano science are both emerging fields that take advantage of molecular-level designing and have enormous potential for advancing our science. Nano science is the study of materials that are on the length-scale of 100 nanometers or smaller and have properties that are dependent on their physical size. The principles of green chemistry can guide responsible development of Nano science, while the new strategies of Nano science can fuel the development ofgreener productsand processes.Phytochemicalsoccluded in tea have been extensively used as dietary supplements and as naturalpharmaceuticalsin the treatment The parallel development of green chemistry and Nano science and the potential synergy of the two fields can lead to more successful and profitable technologies with reduced environmental impacts and improved conservation of resources. In recent years, green synthesis ofmetal nanoparticlesis an interesting issue of the nanoscience.

Nanotechnologyis enabling technology that deals with Nano-meter sized objects. It is expected that nanotechnology will be developed at several levels: materials, devices and systems. The combination of biology and nanotechnology has led to a new generation ofNano devicesthat opens the possibility to characterize the chemical, physical, mechanical, and other molecular properties. And it can be even used to characterize the single molecules or cells at extraordinarily high throughput.Nanoparticleswith distinctive chemical compositions, sizes, shapes, and surface chemistries can be engineered easily and this technique has wide range of applications in biological systems.Utility of nanotechnology to biomedical sciences imply creation of materials and devices designed tointeraction in sub-cellular scaleswith a high degree of specificity.

Biopolymer nanoparticles are offering numerous advantages which embrace the simplicity of their preparation from well-understood biodegradable, biocompatible polymers and their high stability inbiological fluidsduring storage. Since the emergence of Nanotechnology in the past decades, the development and design of organic andbioorganic nanomaterialshas become an important field of research. And several types of polymers have been tested and are used in drug delivery systems; including nanoparticles, dendrimers, capsosomes and micelles. Researchers have found, the synthesized polymers even serves as a good carrier and plays a vital role in carrying a drug. And in other hand they are used in food industries too for food package purposes. There are thousands of organic chemicals are in present in various pharmaceutical to consumer product and are being used in dyes, flavoring agents. It can be explained in organic compounds ranging in diameter from 10 to 1m.Ultrafine particlesare the same asnanoparticlesand between 1 and 100 nanometers in size, fine particles are sized between 100 and 2,500 nanometers, and coarse particles cover a range between 2,500 and 10,000nanometers.

The biological synthesis ofnanoparticlesis synthesis method through which we can control, size and shape of nanoparticles and it increasingly regarded as a rapid, ecofriendly, and easily scaled-up technology. Over the past few years researches have shown their interest inmetallic nanoparticlesand their synthesis has greatly increased. However, drawbacks such as the involvement oftoxic chemicalsand the high-energy requirements of production. Synthesizing living organisms such as bacteria, fungi and plants is an alternative way to overcome the drawbacks. Plant mediated synthesis of nanoparticles is the green chemistry that connects. Generally, metal nanoparticles are synthesized and stabilized by using physical and chemical: the chemical approach, such as chemical reduction,electrochemical techniques,photochemical reactionsin reverse micelles. There is a growing attention to biosynthesis the metal nanoparticles using organisms. Among these organisms, plants seem to be the best candidate and they are suitable for large scale biosynthesis of nanoparticles.

Nanoparticles used asdrug deliveryvehicles are generally below 100 nm , and are coated with different biodegradable materials such as natural or synthetic polymers (PEG,PVA,PLGA,etc.), lipids, or metals , it plays significant role on cancer treatment as well as it holds tremendous potential as an effective drug delivery system. A targeted drug delivery system (TDDS) is a system, which releases the drug in a controlled manner. Nanosystems with different compositions and biological properties have been extensively investigated for drug and gene delivery applications. To achieve efficient drug delivery it is important to understand the interactions ofNanomaterialswith the biological environment, targetingcell-surface receptors, drug release, multiple drug administration, stability of therapeutic agents. Nanotechnology refers to structures roughly in the 1100 nm size regime in at least one dimension. Despite this size restriction, nanotechnology commonly refers to structures that are up to several hundred nanometers in size and that are developed bytop-down or bottom-up engineering of individual components.

Nanosuspention formulation can be used to improve the solubility of the poorly soluble drugs. One of the major problems associated with poorly soluble drugs is very low bioavailability. The Preparation ofNanosuspentionis simple and applicable to all drugs which are water insoluble. It consists of the pure poorly water-soluble drug without any matrix material suspended in dispersion . Various techniques are used for the enhancement of the solubility of poorly soluble drugs which include physical and chemical modifications of drug and other methods like particle size reduction,crystal engineering, salt formation, solid dispersion, use ofsurfactant, complexation A range of parameters like solubility, stability at room temperature, compatibility with solvent, excipient, andphotostabilityplay a critical role in the successful formulation of drugs. Use of some drug which is potentially restricted because of its toxic side-effects and its poor solubility, making it unsuitable for intravenous use in patients withdrug malabsorption.

Nano medicine drives the convergence of nanotechnology and medicine it is delineated as the application of nanotechnology in healthcare. The field of tissue engineering has developed in phases: initially researchers searched for inert biomaterialsto act solely as replacement structures in the body. Tissue engineering is classified as an associate field of biomaterialsand engineering. It focuses on the use of cellular and material-based therapies aimed attargeted tissue regenerationcaused by traumatic, degenerative, and genetic disorders.It covers a broad range of applications, in practice the term has come to represent applications that repair or replace structural tissues (i.e., bone, cartilage, blood vessels, bladder, etc.). Today, these Nano scale technologies are coming to the forefront in medicine because of their biocompatibility, tissue-specificity, and integration and ability to act as therapeutic carriers.

Polymeric nanoparticles (NPs) are one of the most studied organic strategies for Nano medicine. Intense interest lies in the potential ofpolymeric NPsto revolutionize modern medicine. Polymeric NPs include drug delivery techniques such as conjugation and entrapment of drugs,prodrugs, stimuli-responsive systems,imaging modalities, and theranostics.The use of biodegradable polymeric nanoparticles (NPs) for controlled drug delivery has shown significanttherapeutic potential. Concurrently, targeted delivery technologies are becoming increasingly important as a scientific area of investigation. Polymericnanoparticles-based therapeutics show great promise in the treatment of a wide range of diseases, due to the flexibility in which their structures can be modified, with intricate definition over their compositions, structures and properties. Advances in polymerizationchemistries and the application of reactive, efficient andorthogonal chemicalmodification reactionshave enabled the engineering of multifunctional polymericnanoparticles.

In recent years,microbubbleand Nano bubble technologies have drawn great attention due to their wide applications in many fields of science and technology, such as water treatment,biomedical engineering, and nanomaterials.Nano bubblesexhibit unique characteristics; due to their minute size and high internal pressure, they can remain stable in water for prolonged periods of time. Nanobubbles can be created whengold nanoparticlesare struck by short laser pulses. The short-lived bubbles are very bright and can be made smaller or larger by varying the power of the laser. Because they are visible under a microscope, nanobubbles can be used to either diagnose sick cells or to track the explosions that are destroying them.

Natural productshave been used in medicine for many years. Many top-sellingpharmaceuticalsare natural compounds or their derivatives.. And plant- or microorganism-derived compounds have shown potential as therapeutic agents against cancer, microbial infection, inflammation, and other disease conditions. Natural products had huge success in the post-World War II era as antibiotics, and the two terms have become synonymous.While large pharmaceutical companies have favored screening synthetic compound libraries for drug discovery, small companies have started to explore natural products uses against cancer, microbial infection, inflammation, and other diseases.The incorporation of nanoparticles into a delivery system for natural products would be a major advance in the efforts to increase their therapeutic effects. Recently, advances have been made showing that nanoparticles can significantly increase the bioavailability of natural products bothin vitro and in vivo.

Nanoscience and nanotechnology are new frontiers of this century and food nanotechnology is an emerging technology. Food technology is regarded as one of the industry sectors where nanotechnology will play an important role in the future. The development of new products and applications involving nanotechnologies holds great promise in different industrial sectors, Nanotechnology may revolutionize the food industry by providing stronger, high-barrier packaging materials, more potentantimicrobial agents. Several possibilities exist to exploit the benefits of nanotechnologies during different phases of the food chain with the aim to enhance animal nutrition and health. Several complex set of engineering and scientific challenges in the food and bioprocessing industries for manufacturing high quality and safe food through efficient and sustainable means can be solved through nanotechnology. Bacteria identification and food quality monitoring using biosensors; intelligent, active, and smart food packaging systems; and Nanoencapsulationofbioactive food compoundsare few examples of emerging applications of nanotechnology for the food industry.

The main current applications of Nanotechnology for surgeons are in the areas of development of surgical implants using Nanomaterials, Imaging, Drug Delivery and development of Tissue Engineering products, such as scaffolds with enhanced materialcell interaction. An example of this is the development of a scaffold for delivery of stem cells to replace defective retinal pigmented epithelial cells in age-related Macular Degeneration. In Dentistry research has been done, liposomal Nanoparticles that contained collagenase and performed tests with them in rats, and found compared to conventional surgery, collagenase weakened the collagen fibers, making it easier to shift the teeth afterward with braces.

Nanoparticles with their unique size-dependent properties are at the forefront of advanced material engineering applications in several fields. Metals, non-metals, bio-ceramics, and manypolymeric materialsare used to produce nanoparticles of the respective materials. These are functional in producing liposomes, PEG and many more. Due to their small size nanoparticles has found to be interacting with human bodies same like of gases. Nanoparticles of the same composition can display behavioral differences when interacting with different environments. Nanoparticles can enter the human body via inhalation, ingestion, or skin contact. The range of pathologiesrelated to exposure tonanoparticles encompasses respiratoryand even several organs and leads to diseases. Accurate in vitro assessment ofnanoparticle cytotoxicityrequires a careful selection of the test systems. Due to high adsorption capacity and optical activity, engineered nanoparticles are highly potential in influencing classical cytotoxicity assays.

One of the exciting features of nanotechnology is its utility in the field of Nano medicine, therapeutics, and medical devices . When these small size materials are introduced into biological systems, their extremely small size and their unique Nano scale properties make it possible to use them as delivery vectors and probes for biological diagnostics,bioimagingand therapeutics. In fact, when size decreases, thesurface area to volume ratioof materials becomes very large, so that a vast suitable surface is available forchemical interactions withbiomolecules. This critically implied that nanotechnology is facing a transition into the tangible advancement ofhuman therapeutics. Recently, There are multiple clinical trials of nanomaterials have done; both for therapeutics and for medical devices.

Related conferences: Nanomedicine Conferences | Nanotechnology Events | Nano Healthcare Congress | Nanomedicine Meet | Nanoscience Event | Nanoengineering Conference | Tissue Engineering Meeting

Related Societies:

USA:International Organization of Materials, International Association of Nanotechnology, Graphene Stakeholders Association, Nano Science and Technology Institute (NSTI),NanoBusiness Commercialization Association, Alliance for Nanotechnology in Cancer,International association of nanotechnology,National Institute for Nanotechnology, Waterloo Institute for Nanotechnology, The Institute for Molecular Manufacturing (IMM),NanoBusiness Alliance, Nanotechnology and Nanoscience Student Association (NANSA),Nano Science and Technology Institute (NSTI),National Cancer Institute, National Nanotechnology Initiative,American Nano society, Metals and Minerals Societies, Society for Advancement of Material and process Engineering,American Composites Manufacturers Association, Brazilian Composites Materials Association,Canadian Biomaterials Society, American Institute of Aeronautics and Astronautics (AIAA).

Europe:International Union of Crystallography, European Nanoscience and Nanotechnology Association (ENNA),German Association of Nanotechnology, Nanotechnology Industries Association, The Institute of Nanotechnology (IoN), Nanotechnology Industries Association (NIA),Russian Society of Scanning Probe Microscopy and Nanotechnology, Society of Nanoscience and Nanotechnology, Federation of Materials Societies, Society for Biomaterials, Federation of European Materials Societies

Asia-Pacific & Middle East:Nano Technology Research Association (NTRA), Asian Nanoscience and Nanotechnology Association (ANNA), Nanoscience & Nanotechnology, ASPEN-Asian society of precision engineering and nanotechology, The International Association of Nanotechnology (IANT), Iran Nanotechnology Initiative Council (INIC), National Institutes of Health, Society of Materials Science, Japan Society for Composite Materials, Australasian Society for Biomaterials and Tissue Engineering, Australasian Ceramic Society, Materials Research Society, National Centre for Nanoscience and Technology.

Theme: Role of Nanotechnology in Humans life

Summary:

The field of Nanotechnology has recently emerged as the most commercially viable technology of this century because of its wide-ranging applications in our daily lives. Man-made Nanostructured materials such as fullerenes, nanoparticles, Nano powders, Nanotubes, Nanowires, Nanorods, Nano-fibers, Quantum dots, Dendrimers, Nano clusters, Nanocrystals, and Nanocomposites are globally produced in large quantities due to their wide potential applications, e.g., in skincare and consumer products, healthcare, electronics, photonics, biotechnology, engineering products, Pharmaceuticals, drug delivery, and agriculture. Many emerging economies such as Brazil, China, India, Iran, UAE, Malaysia, Mexico, Singapore and South Africa have ambitious research and development (R&D) plans for Nanotechnology.A group of scientists who have mapped out the uses of Nanotechnology and the needs of global health argue that Nano medicine is relevant for the developing world. They surveyed researchers worldwide and concluded that Nanotechnology could greatly contribute to meeting the Millennium Development Goals for health.

Importance and scope:

Nanotechnologyis becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including Nano scale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies. Universities also have begun to offer dedicated Nano medicine degree programs (example:MSc program in Nanotechnology for Medicine and Health Care). Nanotechnology will be getting to be progressively prevalent these times Around learners. Actually, if you follow again of the Inception about nanotechnology, you will discover that Ayurveda need long been utilizing gold Also silver nanoparticles, known as bhasmas, to treat Different therapeutic ailments. Presently, nanotechnology may be generally utilized within huge numbers industries, going from cosmetics, agriculture, and materials should pharmaceutical Also human services. Nanomedicine may be the provision for nanotechnology for those diagnoses, detection, and medicine Also aversion of illnesses. Presently there need aid various items on the business that would the outcome from claiming nanotechnology. Talking for scratching the surface, we likewise have Nano auto wax that fills done the individuals minor cracks more successfully Furthermore provides for you a shinier vehicle. There need aid likewise Nano items accessible with stay with your eyewear What’s more different optical units cleaner, dryer, What’s more that’s only the tip of the iceberg tough.

Conference highlights:

Why in Abu Dhabi?

Abu Dhabi is the federal capital and centre of government in the United Arab Emirates sits off the mainland on an island in the Persian (Arabian) Gulf. It is the largest city of the Emirate of Abu Dhabi and one of the most modern cities in the world. It is a well-ordered, industrious city with a pretty waterside location. Innovative Nano Technology LLC was founded in the beginning of 2016 in Al Ain City, Abu Dhabi, United Arab Emirates. It was established with the goal of taking a leading role in the field of Nano Technology Based Coatings, and is considered as one of the first Companies who offer the new Nano technology based Coatings in the region.

Why to attend?

United Arab Emirates has a number of universities that offer research and educational opportunities in nanotechnology. United Arab Emirates University, The first and foremost comprehensive National University in the United Arab Emirates. eFORS office is the University consultancy office within the college of engineering that deals with several science and technology issues including Biochemical and Biopharmaceutical Processes and Bioengineering and Nanotechnology. Reports released during October 2012 revealed that the worlds second largest foundry, Globalfoundries has agreed to partner with Masdar Institute to develop Abu Dhabi as a centre for semiconductor R&D and manufacturing excellence. In September, the company allowed students and professors to use its technology facilities at its Abu Dhabi branch. The facilities have a laboratory-like environment with powerful production servers, engineering work stations and a high-speed data network that can be used for enabling remote access to very advanced nanotechnology engineering systems

Technology domains of patent applications in UAE

This graph shows the global Nanomedicine market size, measured in terms of revenues, such as sales revenues, grants revenues, and milestones. From2006to date, a steady growth has occurred, which is expected to continue through2014, at aCAGRof13.5% [BCCResearch, Nanotechnology in Medical Applications. The drug delivery market is the largest contributing application segment, whereas biomaterials are the fastest growing application area in this market. Nanomedicine accounts for77Marketed Products Worldwide, representing an Industry with an estimated market $249.9Billion by2016[ETPNdata,BCC].

Globally, the industry players would centering essentially once R&D to get Regard for Different clinical trials for future Nanodrugs with a chance to be economically accessible in the business sector. If a chance to be generally arranged for exactly of the most punctual What’s more The greater part essential requisitions of Nano medicine for regions for example, gene treatment and tissue building. The a greater amount propelled requisitions for Nano medicine will pose interesting tests As far as order Furthermore support about exploratory dexterity.

Nano medicine market :

Nano-enabled medical products beganappearing on the market over a decade ago and some have become best-sellers in theirtherapeutic categories. The main areas in which Nanomedical products have made animpact are cancer, CNS diseases, cardiovascular disease, and infection control. At present, cancer is one of the largesttherapeutic areas in which Nano-enabled products have made major contributions; theseinclude Abraxane, Depocyt, Oncospar, Doxil,and Neulasta. Cancer is a prime focus forNano pharmaceutical R&D, and companieswith clinical-stage developments in this fieldinclude Celgene, Access, Camurus, andCytimmune. Treatments for CNS disorders includingAlzheimers disease and stroke also feature prominently in Nano therapeutic research,seeking to build on achievements already posted by products such as Tysabri, Copazone,and Diprivan. According to BCC Research,this is a field hungry for successfultherapeutic advances and annual growth fromexisting and advanced pipeline products isexpected to reach 16% over the next 5 years.

Nanotechnology Companies in Asia and Middle East:

Nano Congress 2017

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Sponsors for making Nano Congress 2017 Conference the best ever!

The19thNano Congress for Next Generation, hosted by the ME Conferences was held duringAugust 31- September 01, 2017atBrussels, Belgiumbased on the themeNext Generation Nanotechnology Concepts Methodologies Tools and Applications”. Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Nanotechnology who made this event a grand success.

ME Conferences expresses its gratitude to the conference Moderator,namelyDr.Dominique Ausserrefor taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Similarly we also extend our appreciation towards our Poster judge namely,Dr. Arturs Medvids.

The conference was initiated with theHonorable presenceof theKeynote forum. The list includes:

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Nano Materials Synthesis and Characterisation

Nano Photonics

Molecular Nanotechnology

Nanotechnology and Cosmetics

Nanotechnology in Agriculture and Food Industry

Carbon Based Nano materials and Devices

Nanotechnology Safety

Nano Medicine and Nano Biotechnology

Nano Science and Technology

Nano Applications

Nano-electronics

Nano Biomaterials

Nano Biometric

Advanced Nanomaterials

Nano Technology in Tissue Engineering

Nanotech for Energy and Environment

Nano Computational Modelling

ME Conferences offers its heartfelt appreciation to organizations such asAllied Academies,Andrew John Publishing Inc.,New York private Equity Forum,Crowd Reviewsand other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. ME Conferences also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and sponsors who supported this event

Continued here:
Nanomedicine Conferences | Nanotechnology Events …

Read the Rest...

What is Nanomedicine? : Center for Nanomedicine

§ July 2nd, 2018 § Filed under Nano Medicine Comments Off on What is Nanomedicine? : Center for Nanomedicine

Nanomedicine is defined as the medical application of nanotechnology. Nanomedicine can include a wide range of applications, including biosensors, tissue engineering, diagnostic devices, and many others. In the Center for Nanomedicine at Johns Hopkins, we focus on harnessing nanotechnology to more effectively diagnose, treat, and prevent various diseases. Our entire bodies are exposed to the medicines that we take, which can lead to unpleasant side effects and minimize the amount of medicine that reaches the places where it is needed. Medications can be more efficiently delivered to the site of action using nanotechnology, resulting in improved outcomes with less medication.

For example, treating cancer with current chemotherapy delivery techniques is like spraying an entire rose garden with poison in order to kill a single weed. It would be far more effective to spray a small amount of poison, directly on the weed, and save the roses. In this analogy, a cancer patients hair follicles, immune cells, and epithelia are the roses being poisoned by the chemotherapy. Using nanotechnology, we can direct the chemotherapy to the tumor and minimize exposure to the rest of the body. In addition, our nanotechnologies are more capable of bypassing internal barriers (see Technologies), further improving upon conventional nanotechnologies. Not only is our approach more effective at eradicating tumors (see Cancer under Research), but it also results in much higher quality of life for the patient.

Nanotechnology can also reduce the frequency with which we have to take our medications. Typically, the human body can very quickly and effectively remove medications, reducing the duration of action. For example, the current treatment for age-related macular degeneration (AMD) requires monthly injections into the eye in a clinical setting. However, if the medication is slowly released from the inside of a nanoparticle, the frequency of injection can be reduced to once every 6 months (see Eye under Research). The nanoparticle itself also slowly biodegrades into components that naturally occur in the body, which are also removed from the body after the medication has done its job. This exciting technology is currently being commercialized and moved toward clinical trials (see Commercialization).

Nanomedicine will lead to many more exciting medical breakthroughs. Please explore our various nanotechnology platforms and the numerous areas in which we are pursuing nanomedicine-based medical solutions.

See the rest here:
What is Nanomedicine? : Center for Nanomedicine

Read the Rest...

Nanomedicine | medicine | Britannica.com

§ May 9th, 2018 § Filed under Nano Medicine Comments Off on Nanomedicine | medicine | Britannica.com

Nanomedicine, branch of medicine that seeks to apply nanotechnologythat is, the manipulation and manufacture of materials and devices that are smaller than 1 nanometre [0.0000001 cm] in sizeto the prevention of disease and to imaging, diagnosis, monitoring, treatment, repair, and regeneration of biological systems.

Although nanomedicine remains in its early stages, a number of nanomedical applications have been developed. Research thus far has focused on the development of biosensors to aid in diagnostics and vehicles to administer vaccines, medications, and genetic therapy, including the development of nanocapsules to aid in cancer treatment.

An offshoot of nanotechnology, nanomedicine is an emerging field and had garnered interest as a site for global research and development, which gives the field academic and commercial legitimacy. Funding for nanomedicine research comes both from public and private sources, and the leading investors are the United States, the United Kingdom, Germany, and Japan. In terms of the volume of nanomedicine research, these countries are joined by China, France, India, Brazil, Russia, and India.

Working at the molecular-size scale, nanomedicine is animated with promises of the seamless integration of biology and technology, the eradication of disease through personalized medicine, targeted drug delivery, regenerative medicine, as well as nanomachinery that can substitute portions of cells. Although many of these visions may not come to fruition, some nanomedicine applications have become reality, with the potential to radically transform the practice of medicine, as well as current understandings of the health, disease, and biologyissues that are of vital importance for contemporary societies. The fields global market share totalled some $78 billion dollars in 2012, driven by technological advancements. By the end of the decade, the market is expected to grow to nearly $200 billion.

Nanomedicine derives much of its rhetorical, technological, and scientific strength from the scale on which it operates (1 to 100 nanometers), the size of molecules and biochemical functions. The term nanomedicine emerged in 1999, the year when American scientist Robert A. Freitas Jr. published Nanomedicine: Basic Capabilities, the first of two volumes he dedicated to the subject.

Extending American scientist K. Eric Drexlers vision of molecular assemblers with respect to nanotechnology, nanomedicine was depicted as facilitating the creation of nanobot devices (nanoscale-sized automatons) that would navigate the human body searching for and clearing disease. Although much of this compelling imagery still remains unrealized, it underscores the underlying vision of doctors being able to search and destroy diseased cells, or of nanomachines that substitute biological parts, which still drives portrayals of the field. Such illustrations remain integral to the field, being used by scientists, funding agencies, and the media alike.

Attesting to the fields actuality are numerous dedicated scientific and industry-oriented conferences, peer-reviewed scientific journals, professional societies, and a growing number of companies. However, nanomedicines identity, scope, and goals are a matter of controversy. In 2006, for instance, the prestigious journal Nature Materials discussed the ongoing struggle of policy makers to understand if nanomedicine is a rhetorical issue or a solution to a real problem. This ambivalence is reflected in the numerous definitions of nanomedicine that can be found in scientific literature, that range from complicated drugs to the above mentioned nanobots. Despite the lack of a shared definition, there is a general agreement that nanomedicine entails the application of nanotechnology in medicine and that it will profoundly impact medical practice.

A further topic of debate is nanomedicines genealogy, in particular its connections to molecular medicine and nanotechnology. The case of nanotechnology is exemplary: on one hand, its potentialin terms of science but also in regard to funding and recognitionis often mobilized by nanomedicine proponents; on the other, there is an attempt to distance nanomedicine from nanotechnology, for fear of being damaged by the perceived hype that surrounds it. The push is then for nanomedicine to emerge not as a subdiscipline of nanotechnology but as a parallel field.

Although nanomedicine research and development is actively pursued in numerous countries, the United States, the EU (particularly Germany), and Japan have made significant contributions from the fields outset. This is reflected both in the number of articles published and in that of patents filed, both of which have grown exponentially since 2004. By 2012, however, nanomedicine research in China grew with respect to publications in the field, and the country ranked second only to the United States in the number of research articles published.

In 2004, two U.S. funding agenciesthe National Institutes of Health and the National Cancer Instituteidentified nanomedicine as a priority research area allocating $144 million and $80 million, respectively, to its study. In the EU meanwhile, public granting institutions did not formally recognize nanomedicine as a field, providing instead funding for research that falls under the headers of nanotechnology and health. Such lack of coordination had been the target of critiques by the European Science Foundation (ESF), warning that it would result in lost medical benefits. In spite of this, the EU ranked first in number of nanomedicine articles published and in 2007 the Seventh Framework Programme (FP7) allocated 250 million to nanomedicine research. Such work has also been heavily funded by the private sector. A study led by the European Science and Technology Observatory found that over 200 European companies were researching and developing nanomedicine applications, many of which were coordinating their efforts.

Much of nanomedicine research is application oriented, emphasizing methods to transfer it from the laboratory to the bedside. In 2005 the ESF pointed to four main subfields in nanomedicine research: analytical tools and nanoimaging, nanomaterials and nanodevices, novel therapeutics and drug delivery systems, and clinical, regulatory, and toxicological issues. Research in analytical tools and nanoimaging seeks to develop noninvasive, reliable, cheap, and highly sensitive tools for in vivo diagnosis and visualization. The ultimate goal is to create fully functional mobile sensors that can be remotely controlled to conduct in vivo, real-time analysis. Research on nanomaterials and nanodevices aims to improve the biocompatibility and mechanical properties of biomaterials used in medicine, so as to create safer implants, substitute damaged cell parts, or stimulate cell growth for tissue engineering and regeneration, to name a few. Work in novel therapeutics and drug delivery systems strives to develop and design nanoparticles and nanostructures that are noninvasive and can target specific diseases, as well as cross biological barriers. Allied with very precise means for diagnosis, these drug delivery systems would enable equally precise site-specific therapeutics and fewer side effects. The area of drug delivery accounts for a large portion of nanomedicines scientific publications.

Finally, the subfield of clinical, regulatory, and toxicological issues lumps together research that examines the field as a whole. Questions of safety and toxicology are prevalent, an issue that is all the more important given that nanomedicine entails introducing newly engineered nanoscale particles, materials, and devices into the human body. Regulatory issues revolve around the management of this newness, with some defending the need for new regulation, and others the ability of systems to deal with it. This subfield should also include other research by social scientists and humanists, namely on the ethics of nanomedicine.

Combined, these subfields build a case for preventive medicine and personalized medicine. Building upon genomics, personalized medicine envisions the possibility of individually tailored diagnostics and therapeutics. Preventive medicine takes this notion further, conjuring the possibility of treating a disease before it manifests itself. If realized, such shifts would have radical impacts on understandings of health, embodiment, and personhood. Questions remain concerning the cost and accessibility of nanomedicine and also about the consequences of diagnostics based on risk propensity or that lack a cure.

See the original post here:
Nanomedicine | medicine | Britannica.com

Read the Rest...

EUNCL | Nanomedicine Characterisation Laboratory

§ April 4th, 2018 § Filed under Nano Medicine Comments Off on EUNCL | Nanomedicine Characterisation Laboratory

European Nanomedicine Characterisation Laboratory

Our Mission is to provide a trans-disciplinary testing infrastructure covering a comprehensive set of preclinical characterisation assays (physical, chemical, in-vitro and in-vivo biological testing) allowing researchers to fully comprehend the bio distribution, metabolism, pharmacokinetics, safety profiles and immunological effects of their Med-NPs.

We are fostering the use and deployment of standard operating procedures (SOPs), benchmark materials, and quality management for the preclinical characterisation of Med-NPs (nanoparticles used for medical applications).

As nanomedicine is a fast evolving field of research, it is a key objective for EUNCL to constantly refine and adapt its assay portfolio and processes in order maintain the provision of state-of-the-art TNA to the scientific community. Therefore, we will progressively implement additional assays to increase our characterisation capacity, for instance in terms of medical application or route of administration.

The emphasis of the EUNCL is to serve as a nexus for trans-disciplinary research, development and clinical applications of nanotechnology. Therefore, lessons-learned, best practices, knowledge, tools and methods will be made available to the scientific community such as academic researchers, industry, regulatory bodies, metrology institutes and others. However, care will be taken to ensure that proprietary information and materials disclosed to the EUNCL by the TNA users are protected.

Original post:
EUNCL | Nanomedicine Characterisation Laboratory

Read the Rest...

Regenerative Nanomedicine Lab – yimlab.com

§ February 28th, 2018 § Filed under Nano Medicine Comments Off on Regenerative Nanomedicine Lab – yimlab.com

Our recent research article “In-vitro Topographical Model of Fuchs Dystrophy for Evaluation of Corneal Endothelial Cell Monolayer Formation” appeared on theBack cover of Advanced Healthcare Materials latest issue.

Several diseases have been known to be caused by microstructural changes in the extracellular microenvironment. Therefore, the knowledge of the interaction of cells with the altered extracellular micro-structures or surface topography is critical to develop a better understanding of the disease for therapeutic development. One such disease is Fuchs corneal endothelial dystrophy (FED). FED is the primary disease and major reason of corneal endothelial cell death. If left untreated, corneal blindness will be resulted; thus, FED is the leading indication for corneal transplantation. In the USA, 4% of population over the age of 40 is believed to have compromised corneal endothelium due to FED, which will further increase due to increasing life expectancy and rapidly ageing population. A diagnostic clinical hallmark of FED is the development of discrete pillar or dome-like microstructures on the corneal endothelial basement membrane (Descemet membrane). These microstructures are called corneal guttata or guttae. Cell therapies have been proposed as an alternative treatment method for Fuchs dystrophy patients. However, currently, no in-vitro or in-vivo FED disease model is available to study the cell therapies before clinical trials.

In this study, the pathological changes in the micro-structure of basement membranes resulting from FED disease was analyzed, to identify geometrical dimension to develop an in-vitro disease model of synthetic corneal guttata pillars/domes by using microfabrication techniques. This model was used to study the monolayer formation of donor-derived human corneal endothelial cells to test the effectiveness of the corneal endothelial cell regenerative therapies. The results suggest that the corneal cell therapies may not be equally effective for patients at different stages of disease progression. The pre-existing guttata in patients could interfere with the cells thus hampering monolayer formation within the eye. Surgical removal of the guttata from the diseased Descemet membrane prior to cell regenerative therapy could increase the success rate of monolayer formation, which could potentially increase the chances of cell therapy success. This study also demonstrate how biomaterial design can be employed to mimic the pathological microstructural changes in basement membranes for better understanding of cellular responses in disease conditions.

Here is the original post:
Regenerative Nanomedicine Lab – yimlab.com

Read the Rest...

nanomedicine company | Nanobiotix

§ February 10th, 2018 § Filed under Nano Medicine Comments Off on nanomedicine company | Nanobiotix

Notre Socit

Depuis plus de 10 ans, Nanobiotix, lun des pionniers et leaders en nanomdecine, a dvelopp une approche rvolutionnaire pour le traitement local du canceret apour objectif dechanger la donne dans le traitement du cancer. Nanobiotix a dvelopp une approche innovante, diffrente des approches classiques des autres socits pharmaceutiques ou biotechnologiques : une nouvelle faon de traiter les patients grce la nanophysique applique au cur de la cellule.

Nanobiotix, spin-off de lUniversit de Buffalo, SUNY, a t cre en 2003. Nanobiotix est cote depuis le 29 octobre 2012 sur le march rglement dEuronext Paris (Code ISIN: FR0011341205, code mnemonic Euronext: NANO, code Bloomberg: NANO:FP).

Nanobiotix exerce ses activits dans le monde entier depuis son sige social situ Paris, en France et depuis sa filiale situe Cambridge, aux Etats-Unis. La Socit a tabli un partenariat avec PharmaEngine pour le dveloppement clinique et la commercialisation de NBTXR3 en Asie-Pacifique.

Nanobiotix concentre son effort sur le dveloppement de son portefeuille de produits entirement brevet, NanoXray. Lobjectif des produits de Nanobiotix est daider des millions de patients recevant une radiothrapie en amliorant son efficacit dans les cellules tumorales, sans augmenter la dose reue par les tissus sains environnants.

Nous dveloppons des produits dits first in class soit premiers de leur classe, avec comme objectif dapporter un maximum de bnfice pour un minimum de modifications des pratiques mdicales, limitant ainsi le cot pour le systme de sant.

Leproduit en tte de dveloppement, NBTXR3, est actuellement test dans un essai clinique denregistrement et la Socit a dpos en aot 2016 le dossier de demande de marquage CE en Europe.

See more here:
nanomedicine company | Nanobiotix

Read the Rest...

Liposome – Wikipedia

§ February 9th, 2018 § Filed under Nano Medicine Comments Off on Liposome – Wikipedia

A liposome is a spherical vesicle having at least one lipid bilayer. The liposome can be used as a vehicle for administration of nutrients and pharmaceutical drugs.[2] Liposomes can be prepared by disrupting biological membranes (such as by sonication).

Liposomes are most often composed of phospholipids, especially phosphatidylcholine, but may also include other lipids, such as egg phosphatidylethanolamine, so long as they are compatible with lipid bilayer structure.[3] A liposome design may employ surface ligands for attaching to unhealthy tissue.[1]

The major types of liposomes are the multilamellar vesicle (MLV, with several lamellar phase lipid bilayers), the small unilamellar liposome vesicle (SUV, with one lipid bilayer), the large unilamellar vesicle (LUV), and the cochleate vesicle.[4] A less desirable form are multivesicular liposomes in which one vesicle contains one or more smaller vesicles.

Liposomes should not be confused with lysosomes, or with micelles and reverse micelles composed of monolayers.[5]

The word liposome derives from two Greek words: lipo (“fat”) and soma (“body”); it is so named because its composition is primarily of phospholipid.

Liposomes were first described by British haematologist Alec D Bangham[6][7][8] in 1961 (published 1964), at the Babraham Institute, in Cambridge. They were discovered when Bangham and R. W. Horne were testing the institute’s new electron microscope by adding negative stain to dry phospholipids. The resemblance to the plasmalemma was obvious, and the microscope pictures served as the first evidence for the cell membrane being a bilayer lipid structure. Their integrity as a closed, bilayer structure, that could release its contents after detergent treatment (structure-linked latency) was established by Bangham, Standish and Weissmann in the next year.[9] Weissmann – during a Cambridge pub discussion with Bangham – first named the structures “liposomes” after the lysosome, which his laboratory had been studying: a simple organelle the structure-linked latency of which could be disrupted by detergents and streptolysins.[10] Liposomes can be easily distinguished from micelles and hexagonal lipid phases by negative staining transmission electron microscopy.[11]

Alec Douglas Bangham with colleagues Jeff Watkins and Malcolm Standish wrote the 1965 paper that effectively launched the liposome industry. Around this time he was joined at Babraham by Gerald Weissmann, an American physician with an interest in lysosomes. Now an emeritus professor at New York University School of Medicine, Weissmann recalls the two of them sitting in a Cambridge pub and reflecting on the role of lipid sheets in separating the interior of the cell from the exterior milieu. This insight, they felt, was to cell function what the discovery of the double helix had been to genetics. Bangham had called his lipid structures multilamellar smectic mesophases or sometimes Banghasomes. It was Weissmann who proposed the more user-friendly term liposome.[12][13]

A liposome has an aqueous solution core surrounded by a hydrophobic membrane, in the form of a lipid bilayer; hydrophilic solutes dissolved in the core cannot readily pass through the bilayer. Hydrophobic chemicals associate with the bilayer. A liposome can be hence loaded with hydrophobic and/or hydrophilic molecules. To deliver the molecules to a site of action, the lipid bilayer can fuse with other bilayers such as the cell membrane, thus delivering the liposome contents; this is a complex and non-spontaneous event, however.[14] By preparing liposomes in a solution of DNA or drugs (which would normally be unable to diffuse through the membrane) they can be (indiscriminately) delivered past the lipid bilayer, but are then typically distributed non-homogeneously.[15]

Liposomes are used as models for artificial cells. Liposomes can also be designed to deliver drugs in other ways. Liposomes that contain low (or high) pH can be constructed such that dissolved aqueous drugs will be charged in solution (i.e., the pH is outside the drug’s pI range). As the pH naturally neutralizes within the liposome (protons can pass through some membranes), the drug will also be neutralized, allowing it to freely pass through a membrane. These liposomes work to deliver drug by diffusion rather than by direct cell fusion.

A similar approach can be exploited in the biodetoxification of drugs by injecting empty liposomes with a transmembrane pH gradient. In this case the vesicles act as sinks to scavenge the drug in the blood circulation and prevent its toxic effect.[16] Another strategy for liposome drug delivery is to target endocytosis events. Liposomes can be made in a particular size range that makes them viable targets for natural macrophage phagocytosis. These liposomes may be digested while in the macrophage’s phagosome, thus releasing its drug. Liposomes can also be decorated with opsonins and ligands to activate endocytosis in other cell types.

The use of liposomes for transformation or transfection of DNA into a host cell is known as lipofection.

In addition to gene and drug delivery applications, liposomes can be used as carriers for the delivery of dyes to textiles,[17] pesticides to plants, enzymes and nutritional supplements to foods, and cosmetics to the skin.[18]

Liposomes are also used as outer shells of some microbubble contrast agents used in contrast-enhanced ultrasound.

Regarding the use of liposomes as a carrier of dietary and nutritional supplements; until very recently the use of liposomes were primarily directed at targeted drug delivery. However, the versatile abilities of liposomes are now being discovered in other settings. Liposomes are presently being implemented for the specific oral delivery of certain dietary and nutritional supplements.[19]

A very small number of dietary and nutritional supplement companies are currently pioneering the benefits of this unique science towards this new application. This new direction and employment of liposome science is in part due to the low absorption and bioavailability rates of traditional oral dietary and nutritional tablets and capsules. The low oral bioavailability and absorption of many nutrients is clinically well documented.[20] Therefore, the natural encapsulation of lypophilic and hydrophilic nutrients within liposomes has made for a very effective method of bypassing the destructive elements of the gastric system and aiding the encapsulated nutrient to be delivered to the cells and tissues.[21]

It is important to note that certain influential factors have far-reaching effects on the percentage of liposome that are yielded in manufacturing.[22] These influences also have an effect on the actual amount of realized liposome entrapment and the actual quality of the liposomes themselves. These are very crucial elements which lead to the long term stability of the liposomes. These complex yet significant factors are the following: (1) The actual manufacturing method and preparation of the liposomes themselves; (2) The constitution, quality, and type of raw phospholipid used in the formulation and manufacturing of the liposomes; (3) The ability to create homogeneous liposome particle sizes that are stable and hold their encapsulated payload. These primary and key elements comprise the foundation of an effective liposome carrier for use in increasing the bioavailability of oral dosages of dietary and nutritional supplements.[23]

The choice of liposome preparation method depends, i.a., on the following parameters:[24][25]

Useful liposomes rarely form spontaneously. They typically form after supplying enough energy to a dispersion of (phospho)lipids in a polar solvent, such as water, to break down multilamellar aggregates into oligo- or unilamellar bilayer vesicles.[3][15]

Liposomes can hence be created by sonicating a dispersion of amphipatic lipids, such as phospholipids, in water.[5] Low shear rates create multilamellar liposomes. The original aggregates, which have many layers like an onion, thereby form progressively smaller and finally unilamellar liposomes (which are often unstable, owing to their small size and the sonication-created defects). Sonication is generally considered a “gross” method of preparation as it can damage the structure of the drug to be encapsulated. Newer methods such as extrusion and Mozafari method [26] are employed to produce materials for human use. Using lipids other than phosphatidylcholine can greatly facilitate liposome preparation.[3]

Further advances in liposome research have been able to allow liposomes to avoid detection by the body’s immune system, specifically, the cells of reticuloendothelial system (RES). These liposomes are known as “stealth liposomes”. They were first proposed by G. Cevc and G. Blume[27] and, independently and soon thereafter, the groups of L. Huang and V. Torchilin[28] and are constructed with PEG (Polyethylene Glycol) studding the outside of the membrane. The PEG coating, which is inert in the body, allows for longer circulatory life for the drug delivery mechanism. However, research currently seeks to investigate at what amount of PEG coating the PEG actually hinders binding of the liposome to the delivery site. In addition to a PEG coating, most stealth liposomes also have some sort of biological species attached as a ligand to the liposome, to enable binding via a specific expression on the targeted drug delivery site. These targeting ligands could be monoclonal antibodies (making an immunoliposome), vitamins, or specific antigens, but must be accessible.[29] Targeted liposomes can target nearly any cell type in the body and deliver drugs that would otherwise be systemically delivered. Naturally toxic drugs can be much less systemically toxic if delivered only to diseased tissues. Polymersomes, morphologically related to liposomes, can also be used this way. Also morphologically related to liposomes are highly deformable vesicles, designed for non-invasive transdermal material delivery, known as Transfersomes.[30]

Certain anticancer drugs such as doxorubicin (Doxil) and daunorubicin may be administered via liposomes. Liposomal cisplatin has received orphan drug designation for pancreatic cancer from EMEA.[citation needed]

Read this article:
Liposome – Wikipedia

Read the Rest...

Nanodelivery 2018 Conferences | Nanomedicine Meetings …

§ December 12th, 2017 § Filed under Nano Medicine Comments Off on Nanodelivery 2018 Conferences | Nanomedicine Meetings …

Welcome Message

International Conference and Exhibition on Nanomedicine and Drug Delivery May 14-16, 2018 Tokyo, Japan

ConferenceSeries Ltdis a renowned organization that organizes highly notable Pharmaceutical Conferencesthroughout the globe. Currently we are bringing forthInternational Conference on Nanomedicine and Drug Delivery(NanoDelivery 2018) scheduled to be held duringMay 14-16, 2018 at Tokyo, Japan. The conferenceinvites all the participants across the globe to attend and share their insights and convey recent developments in the field of Nanomedicine and Drug Delivery.

ConferenceSeries Ltdorganizes aconference seriesof 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientificsocietiesand publishes 700+Open access Journalswhich contains over 50000 eminent personalities, reputed scientists as editorial board members.

2018 Highlights:

Nanomedicine and drugdelivery will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nano medicine and drug delivery respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as Japan, China, India and other economies in the region. Japan is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.This conference seeks to showcase work in the area of Nanomedicine, Drug Delivery Systems, and nanotechnology, Nanobiothechnology, particularly related to drug delivery.

For More PS: http://nanomedicine.pharmaceuticalconferences.com/

(Click here for any queries)

Nanomedicine and drugdelivery can address one of the greatest challenges in the post-genomic era of the 21st century making the essential connections between Academics and industry professionals.

To meet these challenges, the field of Nanomedicine and drugdelivery has undergone exponential growth during the last 5 years. Technologies such as Personalized Nanomedicine, Design of Nanodrugs, Synthesis of Nanoparticles for Drug Delivery, Regenerative Medicine and Tissue Engineering, Nanomedicines and Biomedicalapplications, Nanomaterials for drug delivery, Regulatory Aspects Towards Approval of Nanomedicine, NanoPharmaceutical Industry and Market processing and drug delivery promise to transform the world of nanomedicines and drug delivery much in the same way that integrated and transformed the world of pharmaceutical sciences.

Nanodelivery 2018 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in nanomedicine and drugdelivery, where all attendees can interact with the panel followed by a Q&A session.

Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial board meeting: Discussing on growth and development of open access Nanomedicine and drugdelivery International Journals and recruiting board members and reviewers who can support the journal.

Round table meetings: Providing a platform where industry professionals meet academic experts.

Over 50+ organizations and international pavilions will be exhibiting at the Nanodelivery 2017 conference and Exhibition. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will see at the Nanodelivery Exhibition, you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from todays industry leaders.

The Nanodelivery 2018 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!

Who’s Coming to Nanodelivery 2018?

The field of Nano Delivery now has pivotal roles in electronics, biology and medicine. Its application can be appraised, as it involves the materials to be designed at atomic and molecular level. Due to the advantage of their size, nanospheres have been shown to be robust drug delivery systems and may be useful for encapsulating drugs and enabling more precise targeting with a controlled release. In this review specifically, we highlight the recent advances of this technology for medicine and drug delivery systems. Nanomaterials range from 10200 nm up to a few micrometres in size, and include nano- and microparticles, nanotubes and quantum dots.

Nanotechnological devices are made from metals, polymers, lipids and organic substances as well as from macromolecules such as dendrimers, antibodies, micelles, liposomes and nanofibers. Nanomedicine makes use of these nanostructures for diagnostic or therapeutic applications in all fields of medicine, using them for drug delivery, biosensors, neuro-electronic interfaces, in vivo imaging, and cell-specific molecular interactions, where “cell repair machines” could revolutionize medicine and the medical field. As drug delivery systems, nanoparticles can be designed to improve the pharmacological and therapeutic properties of drugs. The strength of nanoparticulate drug delivery systems is their ability to alter the pharmacokinetics and biodistribution of drugs.

ConferenceSeries Ltdorganizes aconference seriesof 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientificsocietiesand publishes 700+Open access journalswhich contains over 30000 eminent personalities, reputed scientists as editorial board members.

Track 1: Nanomedicine

Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, and Nanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, since nanomedicines must be biocompatible for clinical application.

Related Conferences:

Nanomaterials Conference,March 30-31, 2017, Madrid, Spain;MedicalNanotechnologySummitMay 22-23, 2017, Osaka, International Conference onPharmaceutics and Drug Delivery, March 13-15, 2017 London, UK; 2ndInternational Conference onNanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19th International Conference onNanotechnology and Nanomedicine, July 9 – 10, 2017, Prague, Czech Republic; EuropeanNanomedicineMeeting 2017, April 3-4, 2017, London, UK; 19thInternational Conference onNanotechnology and Nanomedicine, June 21 – 22, 2017, Vienna, Austria; 4thWorld Congress and Expo onNanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain. Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine,Royal Society-NanoTechnology and NanoScience.

Track 2: Design of Nanodrugs

To reach target cell, designing of nanodrugs are major aspects, where researcher interested for developing novel Nanodrugs.

Aimed and specially designed session for researchers developing Nanodrugs for delivery of amino acids, Nucleic acids and proteins. The session Design of Nanodrugs includes: Novel Drugs to Nano Drugs, Nanodrugs for Cancer Therapy, Nanodrugs for Veterinary Therapeutics, Nanodrugs for Medical applications and Nanodrugs for Herbal medicines and Cosmetics.

Related conferences:

Nanomaterials Conference,March 30-31, 2017, Madrid, Spain;MedicalNanotechnologySummitMay 22-23, 2017, Osaka, International Conference onPharmaceutics and Drug Delivery, March 13-15, 2017 London, UK; 2ndInternational Conference onNanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19th International Conference onNanotechnology and Nanomedicine, July 9 – 10, 2017, Prague, Czech Republic; EuropeanNanomedicineMeeting 2017, April 3-4, 2017, London, UK; 19thInternational Conference onNanotechnology and Nanomedicine, June 21 – 22, 2017, Vienna, Austria; 4thWorld Congress and Expo onNanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain. Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine,Royal Society-NanoTechnology and NanoScience.

Track 3: Nanomedicine and Nanotechnology

Nanotechnology for cancer is a field that incorporates the studies related to nanosized particles, their function and behavior with respect to different systems. The tremendous capabilities of nanoparticles have changed the perspective and scope of nanotechnology towards development into an adjuvant field for the remaining fields of life sciences. The role of nanotechnology in the field of pharmaceutics has tremendously changed the way of our understanding about drugs, nanodrugs or the use of nanoparticles as carrier of drug has become the basic fundamental or criteria for the production or design of a drug and advances in nanotechnology.

Nanotechnology is an important field of modern research dealing with design, synthesis, and manipulation of particle structures ranging from approximately 1-100 nm.

The session Design of Nanomedicine and Nanotechnology includes broad topics like: Carbon Nanotubes, Nanoparticles, Gold Nanoparticles, Silver Nanoparticles, Magnetic Nanoparticles, Nano Micro Particles, Nanocomposite Microspheres, Biosensors and Nanobioelectronics, Bio inspired materials and drug delivery and Nanobiomechanics and Nanomedicine.

Related conferences:

Nanomaterials Conference,March 30-31, 2017, Madrid, Spain;MedicalNanotechnologySummitMay 22-23, 2017, Osaka, International Conference onPharmaceutics and Drug Delivery, March 13-15, 2017 London, UK; 2ndInternational Conference onNanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19th International Conference onNanotechnology and Nanomedicine, July 9 – 10, 2017, Prague, Czech Republic; EuropeanNanomedicineMeeting 2017, April 3-4, 2017, London, UK; 19thInternational Conference onNanotechnology and Nanomedicine, June 21 – 22, 2017, Vienna, Austria; 4thWorld Congress and Expo onNanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain. Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine,Royal Society-NanoTechnology and NanoScience.

Track 4: Synthesis of Nanoparticles for Drug Delivery

Nanoparticles (NPs) have wide range of applications in areas such as health care, cosmetics, food and feed, environmental health, mechanics, optics, biomedical sciences, chemical industries, electronics, space industries, drug-gene delivery, energy science, optoelectronics, catalysis, single electron transistors, light emitters, nonlinear optical devices, and photo-electrochemical applications.

Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such as liposomes are used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle

Nanocarriers, Gold Nanoparticles, Silver Nanoparticles, Liposomes, ligands, Nanoemulsions , Solid Lipid Nanoparticles, Polymeric Nanoparticles, Dendrimer Nanocarriers, Silica materials and Carbon Nanocarriers, nanotechnology and medicine.

Related conferences:

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain; MedicalNanotechnologySummit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech Expo December 5-7 2016, USA; International Conference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; International Conference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; International Conference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting and Expo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 5: Regenerative Medicine and Tissue Engineering

The promise of regenerative medicine is truly remarkable. Regenerative medicine is a new branch of medicine that attempts to change the course of chronic disease, in many instances regenerating failing organ systems lost due to age, disease, damage, or congenital defects. The area is rapidly becoming one of the most promising treatment options for patients suffering from tissue failure.

Tissue Engineering and Regenerative Medicine is appealing to scientists, physicians, and lay people alike: to heal tissue or organ defects that the current medical practice deems difficult or impossible to cure.

It covers numerous topics, such as stem cells, cell culture, polymer synthesis, novel biomaterials, drug delivery, therapeutics, and the creation of tissues and organs.

This session dedicated to helping provide research-based solutions to issues related to human diseases and include with sessions as: tissue engineering, Organ fabrication, Tissue printing, Biomaterials, Biologic scaffolds, Hydrogels, Cell seeded matrices, Bioreactor design, Mechanical conditioning of engineered tissues, Mechanical properties of engineered tissues, Physiological properties of engineered tissues, Clinical outcomes of engineered tissue implantation, Cell-based therapies.

Related conferences:

Tissue Engineering and Regenerative Medicine Conference Aug 20-22, 2017 Baltimore, USA; Stem Cell And Regenerative Medicine Meetings March 20-22, 2017 Berlin, Germany; 8thWorld Congress on Stem Cell ResearchMarch 20-22, 2017 Orlando, USA; 5th International Conference onCell and Gene TherapyMay 19-21, 2016 San Antonio, USA; InternationalConference on Restorative MedicineOctober 24-26, 2016 Chicago, USA; InternationalConference on Molecular BiologyOctober 13-15, 2016 Dubai, UAE; 2nd InternationalConference on Tissue preservation and Biobanking September12-13, 2016 Philadelphia USA;Conference on Cardiac Development, Regeneration and RepairApril 3 7, 2016 Snowbird, Utah, USA; The Conference onStem Cell Development,May 22-26, 2016 Hillerd, Denmark;Conference onHematopoietic Stem Cells: June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency Conference March 22-24, 2016 Kyoto, Japan , Royal Society-NanoTechnology and NanoScience, International Association of Nanotechnology (IANT), American Association for the Advancement of Science , Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 6: Nanomedicine in Theranostics

Theranostic nanomedicine is emerging as a promising therapeutic paradigm. It takes advantage of the high capacity of nanoplatforms to ferry cargo and loads onto them both imaging and therapeutic functions. The resulting nanosystems, capable of diagnosis, drug delivery and monitoring of therapeutic response, are expected to play a significant role in the dawning era of personalized medicine, and much research effort has been devoted toward that goal.

Related Conferences:

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain; MedicalNanotechnologySummit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech Expo December 5-7 2016, USA; International Conference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; International Conference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; International Conference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting and Expo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 7: Nanomedicines and Biomedical Applications

Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, and Nanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, since nanomedicines must be biocompatible for clinical application.

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain; MedicalNanotechnologySummit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech Expo December 5-7 2016, USA; International Conference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; International Conference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; International Conference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting and Expo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 8: Drug Delivery Research

Drug Delivery Conferences attains greater global significance as Drug Delivery plays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. Conference includes topics like lipid Polymers to enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. In vitro & in vivo dissolution testing is required to ensure that drug dissolves at a consistent rate from batch to batch of formulated drug product. Improvement of dissolution rate of poorly soluble drugs can be increased by dissolving them in liquid hydrophilic vehicles followed by soaking on highly porous materials. The major part is to deliver an innovative speech on the latest Targeted drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. Pharmacokinetic behavior in drug design and drug development for safety issues arising either as a result of animal toxicity testing or in the clinical program itself

Related Conferences:

10th Pharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6th Annual Conferences on European Pharma Congress, July 10-12, 2017 Madrid, Spain; 3nd International Conference on Biopharmaceutics June 22-23, 2017 Baltimore, USA; 3nd International Conference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rd World Congress on Pharmacology August 7-9, 2017 Paris, France; 2nd International Conference on Parenterals, December 05-07, 2016 Texas, USA; 2nd International Conference on Injectables December 05-07, 2016, Texas, USA; Respiratory Drug Delivery Conference, April 25-28, 2017 France; Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6th International Conference on Drug Formulation, 6thInternational Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM), The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 9: Novel Drug Delivery Systems

To maximize knowledge of the current researcher on developing drug delivery systems via Novel techniques for Pharmaceutical formulation development, Drug Delivery conference themed quality topics on Liposomes, Dendrimer, Targeted Drug Delivery design, versatile polymer in Drug Delivery and Controlled Drug Delivery, Trans mucosal Drug Delivery, Blood Brain Barrier, Optimization of pharmaceutical products, Sustained Drug Delivery Systems, are a uniquely architect session to play an important role in the fields of pharmaceutical formulation development and Pharmacology.

Related Conferences:

10th Pharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6th Annual Conferences on European Pharma Congress, July 10-12, 2017 Madrid, Spain; 3nd International Conference on Biopharmaceutics June 22-23, 2017 Baltimore, USA; 3nd International Conference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rd World Congress on Pharmacology August 7-9, 2017 Paris, France; 2nd International Conference on Parenterals, December 05-07, 2016 Texas, USA; 2nd International Conference on Injectables December 05-07, 2016, Texas, USA; Respiratory Drug Delivery Conference, April 25-28, 2017 France; Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6th International Conference on Drug Formulation, 6thInternational Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM), The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 10: Smart Drug Delivery Technology

To maximize knowledge of the current researcher on developing drug delivery via Pharmaceutical formulation, Smart Drug Delivery conference themed quality topics on Drug Targeting, Drug Designing, Drug evaluation, Drug Delivery and Therapeutics, Biodegradable polymers, Dendrimer a versatile polymer in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry.

Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex

Related Conferences:

10th Pharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6th Annual Conferences on European Pharma Congress, July 10-12, 2017 Madrid, Spain; 3rd International Conference on Biopharmaceutics June 22-23, 2017 Baltimore, USA; 3rd International Conference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rd World Congress on Pharmacology August 7-9, 2017 Paris, France; 2nd International Conference on Parenterals, December 05-07, 2016 Texas, USA; 2nd International Conference on Injectables December 05-07, 2016, Texas, USA; Respiratory Drug Delivery Conference, April 25-28, 2017 France; Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6th International Conference on Drug Formulation, 6thInternational Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM), The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 11: Nano Pharmaceuticals

Pharmaceutical Nanotechnology for Drug Delivery using Nanotechnology session plays major role in the future of pharmaceutical research. In this session, we will go over several of the most important features of nanotechnology, anticancer drug development , pharmocology of cancer drugs, that will impact our lives but we will also talk about what nanotechnology itself will be like in the future and Investigator specifically from cancer therapy. Interestingly pharmaceutical sciences are using nanoparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient.

Nano technology session includes drug delivery using nanotechnology, Pharmaceutical technology, Nanoparticles permeability to BBB, Cancer drug targets, Nanoparticles application, Pancreatic Cancer, Nanoliposome-mediated delivery, MicroRNA therapeutics, recent breakthroughs in nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarrier, Carriers for nanotechnology, various nanostructures, magnetic nanoparticles. In this review Polymer Nanotechnology for Drug Delivery, Nano composite materials, to deliver highly efficient therapeutic compounds to patient a future aspect of Nanotechnology has a vast future ahead of it and we are constantly making breakthroughs in this industry every day.

Related Conferences:

20th International Conference on Nanoscience, Dec 19-20, 2017 Osaka, Japan 11th International Conference on Molecular Nanotechnology, October 20-22, 2016 Rome, Italy, UK; International Conference on Nano medicine, July 24-25, 2017 Melbourne, Australia; Conference on Nanotechnology in Health Care , July 24-25, 2017 Melbourne, Australia; 3rd International Conference on Biopharmaceutics June 22-23, 2017 Baltimore, USA; 3rd International Conference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rd World Congress on Pharmacology August 7-9, 2017 Paris, France; 2nd International Conference on Parenterals, December 05-07, 2016 Texas, USA; 2nd International Conference on Injectables December 05-07, 2016, Texas, USA; Respiratory Drug Delivery Conference, April 25-28, 2017 France; Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6th International Conference on Drug Formulation, 6thInternational Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM), The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 12:Biopharmaceutics and Biologic Drugs

Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products. The process of movement of drug from its site of administration to the systemic circulation is called as absorption. The concentration of drug in plasma and hence the onset of action, and the intensity and duration of response depend upon the bioavailability of drug from its dosage form. Bioavailability is defined as the rate and extent (amount) of drug absorption.Biologic Drugs, or biologic response modifiers, are medications genetically engineered from a living organism, such as a virus, gene or protein, to simulate the bodys natural response to infection and disease. Biologics target proteins, cells and pathways responsible for the symptoms and damage of rheumatoid arthritis and other types of inflammatory arthritis. Biologic response modifiers (biologics for short) are drugs that are genetically engineered from a living organism, such as a virus, gene or protein, to simulate the bodys natural response to infection and disease.

Related conference:

13th International Conference on Biopharma and Biotherapeutics October 24-25, 2018 Boston, Massachusetts, USA , Global Summit on Biopharma and Biotherapeutics Montreal, Canada May 14-15, 2018, International Conference on Nano Medicine and Nanoparticles April 18-19, 2018 Las Vegas, USA 11th European Biosimilars Congress April 26-27, 2018 Rome, Italy

Track 13: Nano Biotechnology

Nanobiotechnologyis the intersection of nanotechnology and biology. Nanobiotechnology has multitude of potentials for advancing medical science thereby improving health care practices around the world. Nanomedicine is used to treat diseases bygene therapy. Nano biotechnologies are being applied to molecular diagnostics and several technologies are in development.

Related Conferences:

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain; MedicalNanotechnologySummit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech Expo December 5-7 2016, USA; International Conference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; International Conference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; International Conference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting and Expo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 14: Nano Pharmaceutical Industry and Market

Nano Pharmaceutical Industry Companies and Market session is beginning to change for small, medium, and large scale pharmaceutical Co, biopharmaceutical Manufacturing and Industries, generic drugs companies, contract drug delivery companies which can manifest from development to manufacturing. Addressing these instabilities is a great challenge, because of the complexity of the Clinical bio therapeutics themselves. This session includes Rheological behavior, Pharmaceutical Guidelines, Pharmaceutical companies and regulatory guidelines perspectives, Advances in computational modeling for bioavailability, drug Stability of Pharmaceutical products which are driving crucial research into new vaccines and medicines. The pharmaceutical industry and the public sector are thinking differently than before about how to improve access to medicines and advance research and development for neglected diseases.

Related Conferences:

International Conference on Pharma Marketing Conference, November 17-19, 2016 Alicante, Spain; 4th Annual conferences on European Pharma Congress, June 13-15, 2016 Berlin, Germany; 2nd International Conference on Biologic Drugs, September 15-17, 2016 San Antonio, USA; 3rd World Congress on Pharmacology August 08-10, 2016 Birmingham, UK; 2nd International Conference on Parenterals, December 05-07, 2016 Dallas, Texas, USA; 2nd International Conference on Injectables December 05-07, 2016 Dallas, Texas, USA; Respiratory Drug Delivery Conference, April 25-28, 2017 France; Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6th International Conference on Drug Formulation, 6thInternational Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM), The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 15: Regulatory Aspects Towards Approval of Nanomedicine

Nanoethicsis the study ethical and social implications of nanotechnologys. It is an emerging but controversial field.Nanoethics is a debatable field.As the research is increasing on nanomedicine, there are certain regulations to increase their efficacy and address the associated safety issues. Other issues in nanoethics include areas likeresearch ethics, environment,global equity, economics, politics, national security, education, life extension and space exploration.

Related Conferences:

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain; MedicalNanotechnologySummit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech Expo December 5-7 2016, USA; International Conference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; International Conference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; International Conference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting and Expo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Summary of Nanodelivery 2018 Conference:

Nano Delivery 2018is an emerging field of engineering and life sciences that promises to revolutionize medicine and medical technology. There are numerous applications of nanomedicine and Drug Delivery using Nanotechnology in medicinal diagnostics. These include improved imagining of the human (or any) body and detecting tumors that are only a few cells in size.

The idea that pharmaceutical agents should be delivered specifically to diseased cells holds the promise of a variety of benefits. The promise of individualized medicine is that it is efficient. Targeted drug-delivery allows doctors and patients to benefit from small dosages at just the right place and thus from fewer side effects.

Nanomedicine has therapeutic uses as well. Nanotechnology is capable of delivering medication to the exact location where they are needed, hence lesser side effects. It can also be used to destroy harmful organisms or cancer cells by interrupting their division process. Nanoprobes can be made to generate radiation that could kill bacteria, viruses and cancer cells. Nanotechnology also theoretically allows the mimicking of natural biological processes, e.g. repair of damaged tissues or acting as artificial red blood cells to transport oxygen.

The global market for healthcare nanotechnology is expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%, according to a new study by Grand View Research, Inc. Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.

Importance & Scope of Nano Delivery:

View post:
Nanodelivery 2018 Conferences | Nanomedicine Meetings …

Read the Rest...

What is Nanomedicine? The future of medicine.

§ October 28th, 2017 § Filed under Nano Medicine Comments Off on What is Nanomedicine? The future of medicine.

Materials which have at least one dimension less than 100nm are classified as nanomaterials. These materials can be may shapes and sizes like spheres, rods, wires, cubes, plates, stars, cages, pyramids among some funny named shapes like nanohedgehogs, nanocandles and nanocakes! See the paperMorphology-Controlled Growth of ZnO Nanostructures Using Microwave Irradiation: from Basic to Complex Structuresfor some really inventive names for various shaped nanomaterials!

Aside scientists are pretty terrible at naming things, for example,the creative names given to optical telescopes the Extremely Large Telescope,Large Binocular Telescope,Overwhelmingly Large Telescope,Very Large Optical Telescope.

These nanoparticle shapes come in different sizes and different materials too. Broadly we can categorize nanomaterials into two groups organic or inorganic (but it is possible to have a hybrid inorganic-organic nanoparticle too). Organic nanoparticles arent nanoparticles from your local farmers market they are nanoparticles which contain carbon (and often hydrogen too which forms hydrocarbons) whereas most inorganic nanoparticles dont contain carbon atoms. Organic nanomaterials include carbon (except fullerenes) , polymeric and lipid-based nanocarriers. Inorganic nanoparticles include metallic/plasmonic, magnetic, upconversion, semiconductor and silica based nanoparticles.

The main groups of organic nanocarriers are liposomes, micelles, protein/peptide based and dendrimers. Protein/peptide based nanocarriers are amorphous (non-crystalline) materials generally conjugated to the therapeutic agent and is often further functionalised with other molecules. Micelles and liposomes are formed by amphiphilic (both hydrophilic and hydrophobic parts), micelles form monolayers whereas liposomes form bilayers. Lastly, dendrimer nanocarriers are tree-like structures which have a starting atom core (eg. nitrogen) and other elements are added through a series of chemical reactions resulting in a spherical branching structure. This final structure is not unlike blood hemoglobin and albumin macromolecules.

These vesicular nanocarriers can be used to trap both hydrophobic and hydrophilic drugs and even small nanoparticles inside the aqueous/lipid core. This provides protection for drugs and facilitates significant drug loading minimising toxicity and increasing blood circulation time (increasing possibility that the drug will reach the therapeutic target from avoiding opsonisation).

inorganic nanomaterials are stable, robust, resistant, highly functional. and are quite easily cleared from the body. Furthermore, inorganic material exhibit truly exciting mechanical, optical, physical and electrical phenomena at the nanoscale which can be tailored through changes in material, phase, shape, size and surface characteristics. Oftentimes, it is necessary to add a biocompatible surface to inorganic nanoparticles to avoid toxicity, especially for heavy metals.

Semiconductor Nanomaterials

Quantum dots are the most well-known semiconductor nanoemitter. These are typically very small in size ~5nm, which is smaller or equal to the exciton Bohr radius giving quantum confinement. Electrons are subatomic particles with a negative elementary electric charge, electron holes is an empty position in an atom or lattice that an electron could occupy. An exciton is a bound statewhere an electron and electron hole are electrostatically attracted to each other through Coulombic forces.Anexciton bohr radiusis the separation distance between the hole and electron. Due to 3 dimensional confinement effects, quantised energy levels are produced in the filled low energy valence band and in the empty conduction band of the quantum dots which is very unlike bulk semiconductors. The energy gap between the conduction and valance band varies with the size of the quantum dot which explains the tunable emissions (colour) when excited. Additionally, alloyed quantum dots can be further tuned because the bandgap is approximately equal to the weighted average of the composite semiconductor material. Quantum dots excited in the near-infrared are expected to be revolutionary in biomedical imaging. There has been concerns about the stability and toxicity, as many quantum dots lose luminescence intensity when exposed to light/air/oxygen/water and they are generally composed of heavy metal materials.

Upconversion Nanomaterials

Upconversion nanomaterials consist of two parts, first the host dielectric lattice (e.g., NaYF4) with one or more guest trivalent lanthanide (atomic numbers 5771) ions (e.g., Er3+, Yb3+). Upconversion is an anti-stokes process, two or more lower energy photons are absorbed (either simultaneously or stepwise) via long-lived real electronic states of the lanthanide dopant and a higher energy photon is emitted. The lanthanide element has a specific electronic configuration with energy levels which is usually independent of the host material type, the nanoparticle shape and its size.

Electrons are arranged in shells around an atoms nucleus, where the closest electrons to the nucleus have the lowest energy. Each shell can hold a certain number of electrons (principal quantum number) the first shell (1) can hold 2 electrons, the second (2) 8 and the third (3) 18. Within these shells are subshells (defined by theazimuthal quantum number) and are labelled s,p,d or f which can hold 2,6,10 or 14 electrons respectively.

In the case of upconversion, the 5s and 5p shells are full whereas the 4f-4f shells are not. But, because 5s and 5p are full they shield the 4f-4f shells which allows sharp line-like luminescence, i.e. the luminescencepeak is not broad. This luminescence is also resistant to photobleaching, high photostability and are nonblinking, which of course is beneficial over fluorescent molecules which experience high levels of degradation. Through careful design, upconversion nanomaterials can display a variety of emission and excitation wavelengths from UV to NIR.

These upconversion nanoparticles can be incorporated with photosensitizers to produce reactive oxygen species which generally require activation by UV light. This therapy procedure is calledPhotodynamic therapyand can be used for treating a wide range of medical conditions including malignant cancers and acne. Upconverison nanomaterials also have applications in multimodal imaging through the use of specific dopants high atomic number dopants for computed tomography (CT) imaging, radioisotopes for single-photon emission tomography (SPECT) imaging or positron emission tomography(PET) imaging.

MagneticNanomaterials

At the nanoscale, certain magnetic materials below a specific size exhibit a special form of magnetism called superparamagnetism. Superparamagnetic nanoparticles behave as single domain paramagnets when under an external magnetic field but once the field is removed there is no residual magnetisation. Typically, these materials areIron oxide nanoparticles. Additionally, these nanomaterials tend to be non-toxic and can be readily coated with molecules for further functionalization. These nanoparticles are commonly used as MRI contrast agentsinmagnetic resonance imaging (MRI).Furthermore, magnetic nanoparticles can be used in nanotherapy either through magnetic-field-directed drug delivery or through magnetic hyperthermia which involves localized heating of diseased tissues and therefore, cell death.

Silica Nanoparticles

Silica is a highly biocompatible biomaterial which is often used in nanomedicine.

Mesoporous silica nanoparticles are silica nanoparticles which have been template-patterned to have pores throughout the particle. This is done through the use of surfactants likeCetrimonium bromide(CTAB), which is extracted after synthesis leaving holes where the CTAB once was. In these pores, water insoluble materials can be added, such as drugs for chemotherapy, dyes for imaging or even small nanoparticles. These pore sizes can be controlled to encapsulate various sizes of biomolecules. Silica is often used to coat nanoparticles to achieve biocompatibility and to simplify further functionalisation.

PlasmonicNanomaterials

Now, saving the best for last plasmonic nanoparticles.

Plasmonic nanoparticles consist of noble metals like gold, silver, copper and aluminium. At the nanoscale, these materials can supportLocalized surface plasmons, which is a collective oscillation of the free surface electrons at the interface between the nanomaterial and the surrounding dielectric medium when resonance occurs between the natural resonant frequency of the surface electrons and the frequency of the incident light photons. The LSPR can be tuned with the material, size and shape of the nanoparticle.

Plasmonic nanoparticles can scatter and absorb light, for example, for smaller nanoparticles absorption tends to dominate (more light is absorbed which is generally converted to heat energy) and for larger nanoparticles scattering tends to dominate (which is exploited in bioimaging). For this reason, smaller nanoparticles are often used in photothermal therapy. InPhotothermal therapy, plasmonic nanoparticles accumulate in diseased tissues then are irradiated with resonant light, the nanoparticles absorb this light energy and convert it to heat energy, resulting in localised heating of the damaged tissue. This localised heating causes cell death, thus this therapy can be used for cancerous tumors. This heating can be visualised using thermographical measurements or using a dark field microspectroscope, plasmon scattering can be used in medical imaging. Please giveBiomedical applications of plasmon resonant metal nanoparticles, Liao et. al.a read for additional information.

Like Loading…

See the article here:
What is Nanomedicine? The future of medicine.

Read the Rest...

British Society for Nanomedicine

§ September 24th, 2017 § Filed under Nano Medicine Comments Off on British Society for Nanomedicine

Welcome to the British Society for Nanomedicine

With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK

A new short course in nanotechnology is now available.

Only 14 places available so register soon.

What is Nanomedicine? Introducing applications of Nanotechnology

Saturday 12th May 2018

Nanomedicines are used globally to improve the lives of patients suffering from a range of disorders including cancer and various infectious diseases. Nanomedicines currently used clinically have overcome a number of issues associated with conventional drug delivery. This interactive workshop will introduce key areas in the development of nanomedicines. The course is presented by multidisciplinary researchers, with expertise in formulation, clinical application, and safety. Additionally, there will be the opportunity to discuss careers in academia. This course would benefit anyone with a general interest in current healthcare research.

University of Liverpool, 126 Mount Pleasant, L69 3GR

Presented by Dr Paul Curley, Dr James Hobson & Dr Neill Liptrott

Click here for more information

To see some of the presentations from this year’s European Nanomedicine Meeting in London click on the presenter’s name below:

Patrick Boisseau, ETPN, France

Nathalie Mignet, The French Society for Nanomedicine (SFNano)

Ulf Andersson, Chairman Nanomed North

Annette Bramley, EPSRC

Mark Platt, Loughborough University

Sylwia Sekula-Neuner, Karlsruhe Institute of Technology

Lea Ann Dailey, KCL, UK

Sven Even Borgos, SINTEF, Norway

Maria de la Fuente, Health Research Institute of Santiago de Compostela (IDIS), Spain

Klaus Weltring, German Platform NanoBioMedicine

Bassem Sabagh, PostNova

Editors-in-Chief Steve Rannard, Raj Bawa, Si-Shen Feng and Andrew Owen

The Journal of Interdisciplinary Nanomedicine (JOIN) is an international peer-reviewed academic journal that aims to provide truly interdisciplinary nanomedicine research. JOIN is now accepting submissions from all relevant fields to be included in the first issue.

The journal contains evidence-based research and translational outputs with high-level contributions from at least two sciences that are peer-reviewed by multiple reviewers tasked to focus primarily on their specialist areas. Multiple first and/or corresponding author status is encouraged so as to provide transparency and acknowledgment for contribution to multidisciplinary work. The Journal embraces submissions from all relevant fields as applied to early stage scientific developments and studies aimed at the progression of nanomedicines towards the clinic, which include engineering, science and medicine, especially materials sciences, life science, clinical science, intellectual property, regulatory issues and policy considerations. JOIN contains original research papers, editorials, review articles, technical notes, and letters to the editor about matters that may benefit the wider readership. Advances that are progressing to application through consolidation of multiple areas of expertise are especially encouraged. Core areas of particular interest include applications of new materials and biological concepts, targeted delivery, molecular biomaterials and nanotechnology in diagnostics, pharmacology, pharmaceutics, toxicology, and clinical outcomes.

For further details please lookhere

Continued here:
British Society for Nanomedicine

Read the Rest...

Nanomed Meeting 2018 | Nanomedicine Conferences| Nanotechnology …

§ September 20th, 2017 § Filed under Nano Medicine Comments Off on Nanomed Meeting 2018 | Nanomedicine Conferences| Nanotechnology …

Meetings International proudly announces the Global Experts Meeting on International Conference and Exhibition onNanomedicine and Nanotechnology Conference scheduled during October 15-17 2018 at Osaka, Japan .With a theme of Challenges and Innovations in next generation medicine”.

Meetings International provides a Global Platform for Nanotechnology Professors, Medical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at its 100+ International Conferences.

TheNanotechnologymarket is valued at USD 12.54 Billion in 2016. This market is expected to grow at a CAGR of 11.7% during the forecast period to reach USD 21.87 Billion by 2021. The new title on Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” predicts that the total nanomedicine market globally will be worth USD 177.60 billion by 2019, growing considerably from its 2012 value of USD 78.54 billion. This market is expected to achieve a compounded annual growth rate of 12.3% between 2013 and 2019.

2017 Highlights:

Nanomed Meeting 2018conference will impact an attractive moment to meet people in the research field and therefore it takes a delight in opening a gate to meet the ability in the field, young researchers and potential speakers. World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields Nanotechnology and engineering, Medical Nanotechnology, tissue engineering are hallmarks of this conference.

Meetings Internationalproudly announces the International Conference and Exhibition on Nanomedicine and Nanotechnology scheduled during Octobder 15-17, 2018 at Osaka, Japan . With a theme of “Challenges and Innovations in next generation medicine”.

Meetings Internationalprovides a Global Platform forNanotechnology, Biotech, Medical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at its 100+ International Conferences.

The popularity of Nanotechnology has increased significantly in recent years. TheNano marketis expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Nanotechnology market offers a promising approach for the delivery of various discoveries, trends,and many innovations. The technology is aimed at maximizing at the targeted site so as to increase the efficiency

Nanotechnology Meetingwill bring together key decision makers and innovators within this rapidly growing field. This intensive 3-Day program will examine various formulation and drug delivery strategies. The event will cover Pre-Formulation,Formulation Aspects, Pharmacokinetics and Pharmacodynamics, Drug Targeting, Drug Delivery Routes,Nano Drug Delivery Systems, Nanotechnology in Drug Delivery, Pharmaceutical Nanotechnology.

Join the industrys leading drug development executives from numerous leading organizations to discuss and hear unique take-home examples, case studies and multiple nano innovations and strategies to assist in reducing time-to-market on future Nano products.

Attend to gain an unmatched experience in theNanotechnologyfield.

Meetings InternationalNanomed Meeting 2018 will offer you an unmatched attendee experience. In addition to the many scientific sessions and take-home case study examples, you will leave this event with many other novel development strategies from some of our workshops and symposiums. Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel drug development and commercialization strategies, which could speed up time to market and save your organization millions. We hope you will join us in Dubai, UAE this november

Sincerely,

Operating Committee

CEO and Founder

Meetings International PTE LTD.

Meetings International Conferences invites all the participants across the globe to attend the Global Nanomedicine and Nanotechnology Conference scheduled during October 15-17, 2018 at Osaka, Japan. Nanomed Meeting 2018 provides a perfect symposium for scientists, engineers, directors of companies and students in the field of Nanotechnology to meet and share their knowledge. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies. It provides a premier technical forum for reporting and learning about the latest research and development, as well as for launching new applications and technology.

Track-1: Nanomedicine

Nanomedicineis simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use ofnanoparticlesto improve the behaviour of drug substances. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain,asthmaand emphysema. Nanomedicine has the potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale. To create precise solutions for intricate medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the RadboudNanomedicine Alliance. The NationalNanotechnologyInitiative expects new commercial applications in the pharmaceutical industry that may include advanced drug delivery systems, new therapies, and in vivo imaging.

Related Associations & societies:

American society for Nanomedicine

British Society for Nanomedicine

European society for Nanomedicine

Track-2: Nanoscience and Technology

Nano Scienceis a technology conductedat theNano scale. It is the applications and study related to extremely small things that can be used around all the other fields of science, like chemistry, biology, physics, engineering and Materials sciences. These particles have the ability to control individual atoms and molecules .Nanotechnologyhas a huge potential to provide technological solutions to many problems in science, energy, physics, environment al and medical fields.

Related Associations & societies:

Indian society for Nanomedicine

European Foundation for Clinical Nanomedicine

French Society for Nanomedicine

Track-3: Molecular Nanotechnology

Molecular Nanotechnology a technological revolution which seeks nothing less than perfectibility. Molecular manufacturing technology can be clean and self-contained.Molecular Nanomanufacturing will slowly transform our connection towards matter and molecules as clear as the computer changed our relationship to information and bits. It will help accurate, inexpensive control of the structure of matter.

Related Associations & societies:

Iranian Society of Nanomedicine

NASA-JSC Area Nano Technology Study Group

Nano Meter-Scale Science and Technology Division of the American Vacuum Society

Track-4: Nano Particles

Nanoparticlesare particles between 1 and 100 nanometers in size. Innanotechnology, a particle is defined as a small object that behaves as a whole unit with respect to its transport and properties.Particlesare further classified according to diameter.Ultrafine particles are the same as nanoparticles and between 1 and 100 nanometers in size, fine particles are sized between 100 and 2,500 nanometers, and coarse particles cover a range between 2,500 and 10,000nanometers.

Related Associations & societies:

American Nano Society

Russian Nanotechnology Corporation

Sri Lanka Institute of Nanotechnology

Track-5: Advanced Nanomaterials

Nanomaterials are characterized as materials with no less than one outside measurement in the size extent from around 1-100 nanometers. Nanoparticles are items with each of the three outside measurements at the nanoscale1. Nanoparticles that are normally happening (e.g., volcanic powder, ash from woodland fires) or are the accidental side effects of ignition procedures (e.g., welding, diesel motors) are generally physically and synthetically heterogeneous and frequently termed ultrafine particles. Built nanoparticles are deliberately delivered and planned with particular properties identified with shape, size, surface properties and science. These properties are reflected in mist concentrates, colloids, or powders. Regularly, the conduct of nanomaterials might depend more on surface region than molecule arrangement itself. World interest for nanomaterials will rise more than more than two times to $5.5 billion in 2016. Nanotubes, nanoclays and quantum dabs will be the quickest developing sorts. The vitality stockpiling and era and development markets will offer the best development prospects. China, India and the US will lead picks up among countries.This study dissects the $2 billion world nanomaterial industry. It presents recorded interest information for the years 2001, 2006 and 2011, and gauges for 2016 and 2021 by material (e.g., metal oxides, chemicals and polymers, metals, nanotubes), market (e.g., social insurance, gadgets, vitality era and capacity, development), world area and for 15 nations.

Related Associations & societies:

Russian Nanotechnology Corporation

National Center for Nanoscience and Technology

International Association of Nanotechnology

Track-6: Nanotechnology in Tissue Engineering

Tissue engineering is one of the fast growing scientific area in this era which is used to create, repair, replace cells, tissues and organs by using cell or combinations of cells with biomaterials . biologically active molecules which helps to produce materials which very much resembles to body’s native tissue/tissues.

Related Associations & societies:

Center for Responsible Nanotechnology

Nanotechnology Industries

The Nanoethics Group

Track-7: Nanomedicine in Drug Delivery

Drug deliverydescribes the method and approach to delivering drugs or pharmaceuticals and other xenobiotic to their site of action within an organism, with the goal of achieving a therapeutic outcome. Issues of pharmacodynamics andpharmacokineticsare important considerations for drug delivery. Designing and developing novel drug delivery systems, with a focus on their application to disease conditions. Preclinical and clinical data related todrug delivery systems. Drug Delivery and Translational Research is a journal published by CRS, providing a unique forum for scientific publication of high-quality research that is exclusively focused onDrug Developmentand translational aspects of drug delivery. Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes. Short-term and long-term biocompatibility of drug delivery systems, host response.Biomaterialswith growth factors for stem-cell differentiation in regenerative medicine and tissue engineering. Devices for drug delivery and drug/device combination products.

Related Associations & societies:

ASME Nanotechnology Institute

Institute of Occupational Medicine, Scotland, UK

Safe Nano, Europe’s Centre of Excellence on Nanotechnology Hazard and Risk

Track-8: Nano Pharmaceuticals

Nano pharmaceuticalsoffer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nano pharmaceuticals represent an emerging field where the sizes of thedrug particleor a therapeutic delivery system work at the Nano scale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nano pharmaceuticals have enormous potential in addressing this failure oftraditional therapeuticswhich offers site-specific targeting of active agents. Such precision targeting via Nano pharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance. In today world economy, a pharmaceutical industry faces enormous pressure to deliver high-quality products to patients while maintaining profitability. Therefore pharmaceutical companies are applyingnanotechnologyto enhance or supplement drug target discovery and drug delivery. Nano pharmaceutical reduces the cost ofdrug discovery, design & development and enhances the drug delivery process.

Related Associations & societies:

Nanometer-Scale Science and Technology Division of the American Vaccum Society

Scottish Center for NanoTechnology in Construction Materials

European NanoTechnology Gateway

Track-9: Nanotechnology in Healthcare

Nanomedicine affects almost all the aspects of healthcare. Nanomedicine helps to engineer novel and advanced tools for the treatment of various diseases and the improvement of human bio systems using molecular Nanotechnology. Cardiovascular diseases, Neurodegenerative disorders, Cancer, Diabetes, Infectious diseases, HIV/AIDS are the main diseases whose treatment can be benefitted by using Nanomedicine.

Related Associations & societies:

Erwin Schrdinger Society for Nanosciences (Austria)

American Academy of NanoMedicine

American Association for the Advancement of Science

Track-10: Biomaterials and Medical Devices

Biomaterials from healthcare viewpoint can be defined as materials those possess some novel properties that makes them appropriate to come in immediate association with the living tissue without eliciting any adverse immune rejection reactions. Biomaterials are in the service of mankind through ancient times but subsequent evolution has made them more versatile and has increased their usage.

Related Associations & societies:

Czech Nano Technology Industries Association

Royal Society-Nano Technology and Nano Science

Erwin Schrodinger Society for Nano Sciences

Track-11: Pharmaceutical Nanotechnology

Nanotechnology is the science which deals with the processes that occur at molecular level and of nanolength scale size. The major studies in the nanotechnology include nanosized particles, their function and behaviour with respect to other systems. The tremendous capabilities of nanoparticles have changed the perspective and scope of nanotechnology towards development into an adjuvant field for the remaining fields of life sciences. Nanotechnology is the ability to understand and control materials at the very smallest scales, from around 100 nm to the dimensions of single atoms; At this Nano scale the properties of these nanosized particles are vary from the conventional medicines.

Related Associations & societies:

Nano Technologies for Tomorrows Society

Nano Technology Research Association

Microscopy Society of America

Track-12: Recent Advances in Nanotechnology

Nano materials and devices play a major role in the field of pharmaceutical nanotechnology. Nanomaterials exhibit properties remarkably different from the properties of the bulk material due to the large surface area to volume ratio that increases the solubility and rate of absorption. Novel nanostructures will helpful for use as artificial tissue engineering and also help to integrate nanodevices with the nervous system that will restore vision and hearing, and build artificial limbs through the implant of new tissue. Nanotechnology is applied in the pharmaceutical industry in such areas as nanomedicine, tissue engineering, nanorobots, biosensors, biomarkers, image enhancement devices and implant technology. Investigations are currently being carried out on, among others, liposomes, dendrimers, metallic nanoparticles, polymeric nanoparticles, CNTs, quantum dots and nanofibres.

Related Associations & societies:

Nano Science and Technology Institute (NSTI)

Nanotechnology and Nanoscience Student Association (NANSA)

Schau-Platz NANO, Munich, Germany

Track-13: Major Challenges in Nanotechnology

At present, nanotechnology has been widely applied to the area of drug development. Nanoparticle-based therapeutics has the ability to overcome biological barriers and to deliver hydrophobic drugs and biologics effectively to the target sites of disease. The complexity of nanoparticles as multi-component 3D structures require careful design and engineering and reproducible scale-up and manufacturing process to achieve a consistent product. The safety and efficacy of nanoparticle-based medicines can be influenced by minor variations in multiple parameters and need to be carefully examined in preclinical and clinical examinations. Finally, nanoparticle-based medicines may have to represent additional development challenges and regulatory considerations compared with conventional medicines. Efforts are being made to produce unique category of therapeutic agents while there is generally a lack of regulatory standards in the examination of nanoparticle-based medicines.

International Conference And Exhibition OnNanotechnology and Nanomedicine

Osaka, Japan October 15-17, 2018

Theme:”Challenges and Innovations in next generation medicine”

STUDY BACKGROUND

While it appears inevitable that nanotechnology will have a broad and fundamental impact on many sectors of the U.S. economy, various technical, marketing and other hurdles need to be overcome before nanotechnology fulfills this promise. These challenges and differences of opinion regarding commercial applications are reflected in the widely diverging estimates of the U.S. and global nanotechnology markets.

Estimates of the global nanotechnology market in 2010 range from about $15.7 billion (the figure used in this report) to $1 trillion. By 2018, the market may be worth more than $2.4 trillion, according to different analysts. These differences reflect not only different analytical methods and assumptions, but also different definitions of the nanotechnology market (e.g., whether to include decades-old technologies such as carbon black rubber reinforcers and photographic silver, or whether to base the market value on nanotechnology inputs alone, as opposed to the total value of products that incorporate nanotechnology).

Perhaps as a reflection of the difficulty of quantifying the market for nanotechnologies, some analysts downplay the commercial dimensions of the nanotechnology market, and focus instead on the supply side, i.e., the development of new nanoscale technologies and applications. These analysts have made valuable contributions, raising investors awareness of and interest in nanotechnologies.

Read the original post:
Nanomed Meeting 2018 | Nanomedicine Conferences| Nanotechnology …

Read the Rest...

Nanobiotechnology Applications, Markets and Companies, 2017-2021 & 2026 – GlobeNewswire (press release)

§ September 7th, 2017 § Filed under Nano Medicine Comments Off on Nanobiotechnology Applications, Markets and Companies, 2017-2021 & 2026 – GlobeNewswire (press release)

Dublin, Sept. 07, 2017 (GLOBE NEWSWIRE) — The “Nanobiotechnology Applications, Markets and Companies” report from Jain PharmaBiotech has been added to Research and Markets’ offering.

The report starts with an introduction to various techniques and materials that are relevant to nanobiotechnology. It includes some of the physical forms of energy such as nanolasers. Some of the technologies are scaling down such as microfluidics to nanofluidic biochips and others are constructions from bottom up. Application in life sciences research, particularly at the cell level sets the stage for role of nanobiotechnology in healthcare in subsequent chapters.

An increasing use of nanobiotechnology by the pharmaceutical and biotechnology industries is anticipated. Nanotechnology will be applied at all stages of drug development – from formulations for optimal delivery to diagnostic applications in clinical trials. Many of the assays based on nanobiotechnology will enable high-throughput screening. Some of nanostructures such as fullerenes are themselves drug candidates as they allow precise grafting of active chemical groups in three-dimensional orientations. The most important pharmaceutical applications are in drug delivery. Apart from offering a solution to solubility problems, nanobiotechnology provides and intracellular delivery possibilities. Skin penetration is improved in transdermal drug delivery. A particularly effective application is as nonviral gene therapy vectors. Nanotechnology has the potential to provide controlled release devices with autonomous operation guided by the needs.

Nanomedicine is now within the realm of reality starting with nanodiagnostics and drug delivery facilitated by nanobiotechnology. Miniature devices such as nanorobots could carry out integrated diagnosis and therapy by refined and minimally invasive procedures, nanosurgery, as an alternative to crude surgery. Applications of nanobiotechnology are described according to various therapeutic systems. Nanotechnology will markedly improve the implants and tissue engineering approaches as well. Of the over 1,000 clinical trials of nanomedicines, approximately 100 are selected and tabulated in major therapeutic areas. Other applications such as for management of biological warfare injuries and poisoning are included. Contribution of nanobiotechnology to nutrition and public health such as supply of purified water are also included.

Future nanobiotechnology markets are calculated on the basis of the background markets in the areas of application and the share of this market by new technologies and state of development at any given year in the future. This is based on a comprehensive and thorough review of the current status of nanobiotechnology, research work in progress and anticipated progress. There is definite indication of large growth of the market but it will be uneven and cannot be plotted as a steady growth curve. Marketing estimates are given according to areas of application, technologies and geographical distribution starting with 2016. The largest expansion is expected between the years 2021 and 2026.

Profiles of 252 companies, out of over 500 involved in this area, are included in the last chapter along with their 183 collaborations.The report is supplemented with 51 Tables, 31 figures and 800 references to the literature.

Key Topics Covered:

Part I: Applications & Markets

1. Introduction

2. Nanotechnologies

3. Nanotechnologies for Basic Research Relevant to Medicine

4. Nanomolecular Diagnostics

5. Nanopharmaceuticals

6. Role of Nanotechnology in Biological Therapies

7. Nanodevices & Techniques for Clinical Applications

8. Nanooncology

9. Nanoneurology

10. Nanocardiology

11. Nanopulmonology

12. Nanoorthopedics

13. Nanoophthalmology

14. Nanomicrobiology

15. Miscellaneous Healthcare Applications of Nanobiotechnology

16. Nanobiotechnology and Personalized Medicine

17. Nanotoxicology

18. Ethical and Regulatory Aspects of Nanomedicine

19. Research and Future of Nanomedicine

20. Nanobiotechnology Markets

21. References

Part II: Companies

22. Nanobiotech Companies

For more information about this report visit https://www.researchandmarkets.com/research/xnnnck/nanobiotechnology

Read this article:
Nanobiotechnology Applications, Markets and Companies, 2017-2021 & 2026 – GlobeNewswire (press release)

Read the Rest...

Nanomedicine – Overview

§ September 6th, 2017 § Filed under Nano Medicine Comments Off on Nanomedicine – Overview

Background

Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for curing disease or repairing damaged tissues, such as bone, muscle, or nerve. A nanometer is one-billionth of a meter, too small to be seen with a conventional lab microscope. It is at this size scale about 100 nanometers or less that biological molecules and structures operate in living cells.

The NIH vision for Nanomedicine is built upon the strengths of NIH funded researchers in probing and understanding the biological, biochemical and biophysical mechanisms of living tissues. Since the cellular machinery operates at the nanoscale, the primary goal of the program – characterizing the molecular components inside cells at a level of precision that leads to re-engineering intracellular complexes – is a monumental challenge.

The teams selected to carry out this initiative consist of researchers with deep knowledge of biology and physiology, physics, chemistry, math and computation, engineering, and clinical medicine. The choice and design of experimental approaches are directed by the need to solve clinical problems (e.g., treatment of sickle cell disease, blindness, cancer, and Huntingtons disease). These are very challenging problems, and great breakthroughs are needed to achieve the goals within the projected 10 year timeframe. The initiative was selected for the NIH Roadmap (now Common Fund) precisely because of the challenging, high risk goals, and the NIH team is working closely with the funded investigators to use the funds and the intellectual resources of the network of investigators to meet those challenges.

10 Year Program Design High Risk, High Reward

The Centers were funded with the expectation that the first half of the initiative would be more heavily focused on basic science with increased emphasis on application of this knowledge in the second five years. This was a novel, experimental approach to translational medicine that began by funding basic scientists interested in gaining a deep understanding of an intracellular nanoscale system and necessitated collaboration with clinicians from the outset in order to properly position work at the centers so that during the second half of the initiative, studies would be applied directly to medical applications. The program began with eight Nanomedicine Development Centers (NDCs), and four centers remain in the second half of the program.

Clinical Consulting Boards (CCBs)

The program has established Clinical Consulting Boards (CCBs) for each of the continuing centers. These boards consist of at least three disease-specific clinician-scientists who are experts in the target disease(s). The intent is for CCBs to provide advice and insight into the needs and barriers regarding resource and personnel allocations as well as scientific advice as needed to help the centers reach their translational goals. Each CCB reports directly to the NIH project team.

Translational Path

In 2011, the PIs of the NDCs worked with their CCBs to precisely define their translational goals and the translational research path needed to reach those goals by the end of the initiative in 2015. To facilitate this, the NIH project team asked them to develop critical decision points along their path. These critical decision points differ from distinct milestones because they may be adjusted based on successes, challenges, barriers, and progress. Similarly, the timing of these decision points may be revised as the centers progress. Research progress and critical decision points are revisited several times a year by the CCB and the NIH team, and when a decision point is reached, next steps are re-examined for relevance, feasibility and timing.

Transition plan

Throughout the program, various projects have been spun off of work at all the centers and most have received funding from other sources. This was by design as work at each center has been shifting from basic science to translational studies. Centers will not be supported by the common fund after 10 years. It is expected that work at the centers will be more appropriately funded by other sources. Pre-clinical targets will likely be developed, and the work at each center will be focused on a specific disease so the work will need to transition out of the experimental space of the common fund.

Support for the NIH Nanomedicine Initiative is provided by the NIH Common Fund, and a team of staff members from across the NIH oversees the program. You may direct questions or comments on the NIH Nanomedicine Initiative to Dr. Richard S. Fisher, Nanomedicine Project Team Leader (nano@nih.gov).

Originally posted here:
Nanomedicine – Overview

Read the Rest...

Global Nanomedicine Industry 2017 Market Growth, Trends and Demands Research Report – MENAFN.COM

§ September 6th, 2017 § Filed under Nano Medicine Comments Off on Global Nanomedicine Industry 2017 Market Growth, Trends and Demands Research Report – MENAFN.COM

(MENAFN Editorial) iCrowdNewswire – Sep 4, 2017

The Global Nanomedicine Market 2017 Industry Research Report’ report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the Global major industry players in detail.

The Global Nanomedicine Market Research Report 2017 renders deep perception of the key regional market status of the Nanomedicine Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, #China and Japan.

Complete report on Nanomedicine market report spread across 116 pages, profiling 12 companies and supported with tables and figuresavailable @

The report on ‘Global Nanomedicine Market is a professional report which provides thorough knowledge along with complete information pertaining to the Nanomedicine industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc.

The potential of this industry segment has been rigorously investigated in conjunction with primary market challenges. The present market condition and future prospects of the segment has also been examined. Moreover, key strategies in the market that includes product developments, partnerships, mergers and acquisitions, etc., are discussed. Besides, upstream raw materials and equipment and downstream demand analysis is also conducted.

Report Includes:-

The report cloaks the market analysis and projection of ‘Nanomedicine Market on a regional as well as global level. The report constitutes qualitative and quantitative valuation by industry analysts, first-hand data, assistance from industry experts along with their most recent verbatim and each industry manufacturers via the market value chain. The research experts have additionally assessed the in general sales and revenue generation of this particular market. In addition, this report also delivers widespread analysis of root market trends, several governing elements and macro-economic indicators, coupled with market improvements as per every segment.

For any Inquire before buying @

Global Nanomedicine market competition by top manufacturers/players, with Nanomedicine sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including: GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., SigmaTau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A

The report is generically segmented into six parts and every part aims on the overview of the Nanomedicine industry, present condition of the market, feasibleness of the investment along with several strategies and policies. Apart from the definition and classification, the report also discusses the analysis of import and export and describes a comparison of the market that is focused on the trends and development. Along with entire framework in addition to in-depth details, one can prepare and stay ahead of the competitors across the targeted locations. The fact that this market report renders details about the major market players along with their product development and current trends proves to be very beneficial for fresh entrants to comprehend and recognize the industry in an improved manner. The report also enlightens the productions, sales, supply, market condition, demand, growth, and forecast of the Nanomedicine industry in the global markets.

Buy a copy of this report @

Every region’s market has been studied thoroughly in this report which deals with the precise information pertaining to the Marketing Channels and novel project investments so that the new entrants as well as the established market players conduct intricate research of trends and analysis in these regional markets. Acknowledging the status of the environment and products’ up gradation, the market report foretells each and every detail.So as to fabricate this report, complete key details, strategies and variables are examined so that entire useful information is amalgamated together for the understanding and studying the key facts pertaining the global Nanomedicine Industry. The production value and market share in conjunction with the SWOT analysis everything is integrated in this report.

Table of Contents

1 Nanomedicine Market Overview 2 Global Nanomedicine Market Competition by Manufacturers 3 Global Nanomedicine Capacity, Production, Revenue (Value) by Region (2011-2016) 4 Global Nanomedicine Supply (Production), Consumption, Export, Import by Regions (2011-2016) 5 Global Nanomedicine Production, Revenue (Value), Price Trend by Type 6 Global Nanomedicine Market Analysis by Application 7 Global Nanomedicine Manufacturers Profiles/Analysis

8 Nanomedicine Manufacturing Cost Analysis 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 10 Marketing Strategy Analysis, Distributors/Traders 11 Market Effect Factors Analysis 12 Global Nanomedicine Market Forecast (2016-2021) 13 Research Findings and Conclusion

About Us

Deep Research Reportsis digital database of syndicated market reports for global and #China industries. These reports offer competitive intelligence data for companies in varied market segments and for decision makers at multiple levels in these organizations. We provide 24/7 online and offline support to our customers.

Connect us

Hrishikesh Patwardhan

Corporate Headquarters

2nd floor, metropole,

Next to inox theatre,

Bund garden road,Pune-411001.

1 888 391 5441

MENAFN0509201700703403ID1095819074

Read the original here:
Global Nanomedicine Industry 2017 Market Growth, Trends and Demands Research Report – MENAFN.COM

Read the Rest...

Nanomedicine Research Journal

§ September 2nd, 2017 § Filed under Nano Medicine Comments Off on Nanomedicine Research Journal

Nanomedicine Research Journal (Abbreviation: Nanomed Res J)

is an international, open access, peer-reviewed, electronic and print quarterly publication released by the Iranian Society of Nanomedicine (ISNM). Nanomedicine Research Journal publishes original research articles, review papers, mini review papers, case reports and short communications covering a wide range of field-specific and interdisciplinary theoretical and experimental results related to applications of nanoscience and nanotechnology in medicine including, but not limited to, diagnosis, treatment, monitoring, prediction and prevention of diseases, tissue engineering, nano bio-sensors, functionalized carriers and targeted drug delivery systems.

* Publication process of manuscripts submitted to Nanomed Res J is free of charge.

To see Acceptance timeline Please follow the link below:

Acceptance Timeline Diagram

About the publisher

Founded in 2011 by the leading ofSchool of Advanced Technologies in medicine (SATiM),Tehran University of Medical Sciences (TUMS) and Iran Nanotechnology Initiative Council, the Iranian Society of Nanomedicine (ISNM) attempts to promote and develop medical nanotechnology in Iran. For more information about the publisher, please visit us at http://isnm.ir/en/.

Read this article:
Nanomedicine Research Journal

Read the Rest...

Eureka Prizes for outstanding science mentor and world-first trials – UNSW Newsroom

§ August 30th, 2017 § Filed under Nano Medicine Comments Off on Eureka Prizes for outstanding science mentor and world-first trials – UNSW Newsroom

UNSW Scientia Professor Justin Gooding has won the Eureka Prize for Outstanding Mentor to Young Researchers, in a night where 12 UNSW and affiliated teams were recognised for excellence.

Also winning one of the prestigious prizes was Dr Lucia Romani, Associate Professor Handan Wand and Professor John Kaldor from the Kirby Institute, and Dr Margot Whitfield from St Vincents Hospital, part of the Scabies Research Team with collaborators from The Murdoch Childrens Research Institute, the Menzies School of Health Research and the Ministries of Health of Fiji and Solomon Islands.

Professor Goodings program of individualised mentorship is credited with creating a buzz in his lab and an environment that is supporting a new breed of research leaders in bionanotechnology and nanomedicine.

He has been a champion of multi-disciplinary research at UNSWas founding co-director of the Australian Centre for NanoMedicine, which draws on the universitys strengths in the Faculties of Science, Engineering and Medicine, as well as the Childrens Cancer Institute of Australia.

Dr Margot Whitfield, Associate Professor Handan Wand, Professor John Kaldor, Dr Lucia Romani, Professor Justin Gooding.

The Scabies Research Group won the Eureka Prize for Infectious Diseases Research for two world-first trials involving mass administration of the drug ivermectin, which reduced the prevalence of scabies from 33% of the population to less than 2%.

They were led by Associate Professor Andrew Steer from the Murdoch Childrens Research Institute in collaboration with The Kirby Institute UNSW, St Vincents Hospital Sydney and Menzies School of Health Research.

UNSW had a record 12 finalists in the running at this year’s Eureka Prizes, Australia’smost high-profile science awards.

The full list of 2017 winners is available here.

Follow this link:
Eureka Prizes for outstanding science mentor and world-first trials – UNSW Newsroom

Read the Rest...

Nanomedicine Market Growth Opportunities for Distributers 2017 – Equity Insider (press release)

§ August 30th, 2017 § Filed under Nano Medicine Comments Off on Nanomedicine Market Growth Opportunities for Distributers 2017 – Equity Insider (press release)

Global Nanomedicine Market Research Report 2017 to 2022 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure of the Nanomedicine Market.

Companies Mentioned are GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A.

Primary sources are mainly industry experts from core and related industries, and suppliers, manufacturers, distributors, service providers, and organizations related to all segments of the industrys supply chain. The bottom-up approach was used to estimate the global market size of Nanomedicine based on end-use industry and region, in terms of value. With the data triangulation procedure and validation of data through primary interviews, the exact values of the overall parent market, and individual market sizes were determined and confirmed in this study.

Sample/Inquire at: https://www.marketinsightsreports.com/reports/08308548/global-nanomedicine-market-research-report-2017/inquiry

This report segments the global Nanomedicine market on the basis of types Regenerative Medicine, In-vitro & In-vivo Diagnostics, Vaccines, Drug Delivery. On the basis of application Clinical Cardiology, Urology, Genetics, Orthopedics, Ophthalmology.

Essential points covered in Global Nanomedicine Market 2017 Research are:-

This independent 116 page report guarantees you will remain better informed than your competition. With over 170 tables and figures examining the Nanomedicine market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leaders market revenue forecasts as well as analysis to 2022.

The global Nanomedicine market consists of different international, regional, and local vendors. The market competition is foreseen to grow higher with the rise in technological innovation and M&A activities in the future. Moreover, many local and regional vendors are offering specific application products for varied end-users. The new vendor entrants in the market are finding it hard to compete with the international vendors based on quality, reliability, and innovations in technology.

Browse Full Report at: https://www.marketinsightsreports.com/reports/08308548/global-nanomedicine-market-research-report-2017

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Storage Area Network Switch in these regions, from 2012 to 2022 (forecast), covering

by Regions

The report provides a basic overview of the Nanomedicine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. Whats more, the Nanomedicine industry development trends and marketing channels are analyzed.

The research includes historic data from 2012 to 2016 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Nanomedicine on the basis of stating current situation of the industry in 2017 so as to make comprehensive organization and judgment on the competition situation and development trend of Nanomedicine Market and assist manufacturers and investment organization to better grasp the development course of Nanomedicine Market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

There are 15 Chapters to deeply display the global Nanomedicine market.

Chapter 1, to describe Nanomedicine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Nanomedicine, with sales, revenue, and price of Nanomedicine, in 2016and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Nanomedicine, for each region, from 2012to 2017;

Chapter 5, 6, 7,8and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Nanomedicine market forecast, by regions, type and application, with sales and revenue, from 2017to 2022;

Chapter 13, 14 and 15, to describe Nanomedicine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Continued here:
Nanomedicine Market Growth Opportunities for Distributers 2017 – Equity Insider (press release)

Read the Rest...

Impact of Existing and Emerging Europe Nanomedicine Market … – MilTech

§ August 29th, 2017 § Filed under Nano Medicine Comments Off on Impact of Existing and Emerging Europe Nanomedicine Market … – MilTech

The global Nanomedicine Market size was estimated at USD XX billion in 2017. Technological advancements coupled with relevant applications in early disease diagnosis, preventive intervention, and prophylaxis of chronic as well as acute disorders is expected to bolster growth in this market.

Download Sample Pages @http://www.kminsights.com/request-sample-33081

Nanotechnology involves the miniaturization of larger structures and chemicals at nanometric scale which has significantly revolutionized drug administration, thus influencing adoption of the technology through to 2022.

Expected developments in nanorobotics owing to the rise in funding from the government organizations is expected to induce potential to the market. Nanorobotics engineering projects that are attempting to target the cancer cells without affecting the surrounding tissues is anticipated to drive progress through to 2022.

Ability of the nanotechnology to serve in diagnostics as well as the therapeutic sector at the same time as a consequence of its characteristic principle to is anticipated to augment research in this sector. Furthermore, utilization of DNA origami for healthcare applications is attributive for the projected growth.

The global nanomedicine market is segmented based on modality, application, indication, and region. Based on application, it is classified into drug delivery, diagnostic imaging, vaccines, regenerative medicine, implants, and others.

On the basis of indication, it is categorized into oncological diseases, neurological diseases, urological diseases, infectious diseases, ophthalmological diseases, orthopedic disorders, immunological diseases, cardiovascular diseases, and others. Based on modality, it is bifurcated into treatments and diagnostics.

The global market is driven by emerging technologies for drug delivery, increase in adoption of nanomedicine across varied applications, rise in government support & funding, growth in need for therapies with fewer side effects, and cost-effectiveness of therapies. However, long approval process and risks associated with nanomedicine (environmental impacts) restrain the market growth.

Download Sample Pages @http://www.kminsights.com/request-sample-33081

Contact:

Mr.Mannansales@kminsights.com+1 (888) 278-7681

About Us:Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

Read the original post:
Impact of Existing and Emerging Europe Nanomedicine Market … – MilTech

Read the Rest...

Expert Radiologist and Clinician Scientist, Michelle S. Bradbury, MD, PhD, is to be Recognized as a 2017 Top Doctor … – PR NewsChannel (press…

§ August 29th, 2017 § Filed under Nano Medicine Comments Off on Expert Radiologist and Clinician Scientist, Michelle S. Bradbury, MD, PhD, is to be Recognized as a 2017 Top Doctor … – PR NewsChannel (press…

Michelle Bradbury MD, PhD, who is a Professor of Radiology, Director of Intraoperative Imaging, and Co-Director of an National Cancer Institute awarded Nanomedicine Center (MSK-Cornell Center for Translation of Cancer Nanomedicines), has been named a 2017 Top Doctor in New York City, New York. Top Doctor Awards is dedicated to selecting and honoring those healthcare practitioners who have demonstrated clinical excellence while delivering the highest standards of patient care.

Dr. Michelle S. Bradbury is a highly experienced physician who has been in practice for over two decades. Her career in medicine started in 1997, when she graduated from the George Washington University School of Medicine and Health Sciences in Washington, D.C. An internship, residency and then fellowship followed, all completed at Wake Forest University in Winston-Salem, North Carolina. Dr. Bradbury also holds a Doctor of Philosophy Degree from the Massachusetts Institute of Technology.

Dr. Bradbury is certified by the American Board of Radiology in both Diagnostic Radiology and Neuroradiology. She is particularly renowned, however, as a leading expert in nanomedicine and in neuroradiology, using CT and MRI imaging of the brain, neck and spine to diagnose conditions of the nervous system. Alongside her work in this field she has been at the forefront of nanomedicine research and clinical trials.

Dr. Bradbury keeps up to date with the latest advances in her field through her active membership of professional organizations including the American College of Radiology, the World Molecular Imaging Congress, and the American Society of Nanomedicine. Her expertise and dedication makes Dr. Michelle S. Bradbury a very deserving winner of a 2017 Top Doctor Award.

About Top Doctor Awards

Top Doctor Awards specializes in recognizing and commemorating the achievements of todays most influential and respected doctors in medicine. Our selection process considers education, research contributions, patient reviews, and other quality measures to identify top doctors

Read the rest here:
Expert Radiologist and Clinician Scientist, Michelle S. Bradbury, MD, PhD, is to be Recognized as a 2017 Top Doctor … – PR NewsChannel (press…

Read the Rest...

« Older Entries





Page 11234..1020..»